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Chapter I 
INTRODUCTION 
I Indications for liver transplantation 
During the past ten years progress in the field of vascular surgery and 
immunology has been such, that a steady improvement in the results of 
clinical organ transplantation can be observed. Also when a life threatening 
disease of the liver is present, liver transplantation may be considered. 
In general these diseases may be described as follows: Necrosis of 
the liver, acute or sub-acute, can give rise to a progressive loss of the liver 
function. The causal factors are very often unknown. Sometimes certain 
hepatotoxins can be indicated as the cause. Halothane, for instance, may 
give rise to acute hepatic necrosis of the liver (Silverman 1975). 
Viral hepatitis can also produce such serious damage to the liver, 
that it endangers life. 
The largest group of patients for whom a liver transplant may be 
considered, consists of those with cirrhosis: appearing for example after 
liver necrosis, prolonged biliary obstruction, metabolic disorders such as 
Wilson's disease or from unknown causes. Cirrhosis, in the long run 
produces a loss ofliver function to such an extent, that too small an amount 
of endogenous poisons are removed, and liver coma ensues. At the same 
time a shortage of protein production gives rise to oedema and/or ascites, 
while a serious lack of coagulation factors may lead to a pronounced 
haemorrhagic diathesis. If cirrhosis is the result of excessive alcohol 
consumption, then, as a rule, a liver transplant will not be considered 
(Starzl I 969, Starzl et a!. 1975, Williams 1970, Rybak 1974 ); in the first 
place because continued alcohol consumption would also endanger the 
new liver and secondly, because in many cases, concurrent disease such 
as pneumonia or chronic bronchitis hamper transplantation of the liver. 
Biliary atresia is the most common life threatening liver disease in 
childhood, usually bringing about a fatal biliary cirrhosis, leading to death 
within a few years of birth. In a series of 39 untreated patients the average 
life span was 19 months. 16 patients (41%) died within I year, 15 died 
between I and 2 years (in total 77% deaths within 2 years) and 8 died at 
an age varying from 27 months to 7'h. years (Hays and Snyder 1963). 
Wilkinson (1973) reported an incidence of congenital biliary atresia of 
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I : 13,000 to 15,000. According to Silverman (!975) the incidence is 
I : 8,000 to I :10,000 but 4 to 5 times higher among "orientals". 
Liver transplantation could be considered for these patients, when biliary 
cirrhosis is well advanced. Kasai (!974) however, reported that after a 
modified hepatoporto-enterostomy operation a cure was observed in 
80% of the cases, provided the operation was performed within I 0 weeks 
of birth. This statement, however, is based solely on a series of 4 patients: 
in all cases the jaundice disappeared and the faeces acquired a normal 
colour whilst only 3 of the patients were kept under observation for 
more than I year. Without giving any figures, Wilkinson (!973) and 
Silverman (1975) appear to be much more pessimistic. They state that 
a mortality of almost I 00% occurs even if the hepatoporto-enterostomy 
operation is performed before the third month. Experience in this type 
of operation, probably plays an important role. 
In conclusion one must state that patients with biliary atresia who 
suffer from biliary cirrhosis are to be considered as candidates for a liver 
transplant. However, since favourable results have been achieved in Japan 
after a modified hepatoporto-enterostomy, a more detailed evaluation of 
this alternative treatment should take place first. For this purpose it is 
necessary that the diagnosis of biliary atresia is made within ten weeks of 
birth. It seems of great importance that these patients are sent to one 
centre in the Netherlands so that one team of paediatricians and 
paediatric surgeons can obtained the necessary experience in treating 
such children. 
Although the removal of a malignant process in the liver can hardly 
be expected to be curative, one does find in the literature than primary 
carcinoma or sarcoma or even localized metastases in the liver have formed 
the motive to remove the liver and replace it by a transplant. No recurrence 
could be found after liver transplantation by the Cambridge-London 
group in 2 out of 12 patients, who originally had hepatic malignancy 
(Williams et a!. 1973 ). In view of these individual successes they consider 
malignant growth, confined to the liver, as an indication for orthotopic 
liver transplantation. 
Starzl found metastases shortly after the operation in every one of a 
series of 6 patients, in whom malignancy was the indication for the trans-
plantation. Only one patient, in whom quite incidentally a small 
hepatoma was found in the resected liver, was still alive 32 months after 
the operation (v. Wyk et a!. 1972). The motive for the transplant in this 
patient however was biliary cirrhosis. Consequently the Denver liver 
transplantation group no longer considers malignancy as a motive for 
liver transplantation (Groth and Starzl 1973). 
II 
2. Incidence of life-threatening liver diseases in the Netherlands 
In order to obtain some impression of the number of patients concerned, 
some data collected by the (Dutch) Central Bureau of Statistics are given 
below, in table I. I. 
Diagnosis 
Necrosis of the liver, acute and sub-acute 
Hepatitis infectiosa 
Congenital anomalies of gall bladder, 
biliary tract or liver 
Cirrhosis, excluding that associated 
with alcohol consumption 
Age group 
0-15 yrs. 15-50 yrs. 
2 
3 
56 
13 
20 
17 
146 
Table I. I. Number of patients dying in the Netherlands during a period of 3 years: 
1970, 1971 and 1972 
35 of the children dying as a result of congenital biliary tract defects 
died before the age of I year, the others before they were 5. Thus, the 
greater part of this group of 56 patients (15 to 20 per year) probably 
suffered from biliary atreasia. This tallies with the number of patients to be 
expected in the Netherlands according to Wilkinson (1973) and 
Silverman (1975): birth rate 150 to 200,000 per annum, incidence of 
± I: I 0,000 _,. 15 to 20 patients with biliary atresia per year. In total, 
according to the C.B.S., 25 patients under 15 and 58 patients from 15 to 
50 years, die each year as a result of the above stated liver diseases. In 
principle these could be considered for liver transplantation, save those 
with additional problems such as obstinate local and/or generalized 
infection. Also patients with biliary atreasia together with severe vascular 
anomalies such as absent inferior vena cava, preduodenal portal vein and 
anomalous hepatic artery, seem to be unsuitable candidates for liver 
transplantation (Lilly and Starzl 1974 ). It is quite clear that the number 
of patients expected to be in need of liver transplantation depends upon 
the indications used. Williams (1970) made such an estimate for Britain. 
According to his view, roughly one half of the patients dying per year 
from diseases such as primary hepatoma (145 patients), primary biliary 
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tract carcinoma (195), cirrhosis (490) and acute hepatitits (160) would 
have been potential recipients of a liver transplant. Thus, while including 
malignant diseases of the liver (in contrast to Starz1 and co-workers), he 
estimates that in Britain approximately 500 patients could be in need of 
liver transplantation per year. Knowing the number of patients who 
actually receive a liver transplant in America(± 15 patients per year) and 
in England(± 8 patients per year) (Bergan 1975, Williams eta!. 1973), it 
is obvious that this number will not be achieved in the near future. 
3. Clinical liver transplantation compared with transplantation of other 
organs. 
How do the results of kidney, heart, lung and pancreas transplantation 
compare with those of liver transplantation? 
As regards kidney transplantation, it may be noted in table 1.2 that 
one year after the operation on average 50% of the cadaver kidneys still 
function. After 2, 3 and 4 years the percentage of functioning cadaver 
kidneys is still 42.6, 41.8 and 40.6% respectively (ACS/NIH, 12th 
Report of the Renal Registry Committee, 1975). 
By comparison, 80, 69 and 60% of the cadaver kidneys transplanted 
in Rotterdam still functioned after I, 2 and 3 years L.D.F.Lameyer 1976, 
personal communication). 
Heart transplantation was reported 257 times to the ACS/NIH from 
!967 to 1975 (Bergan 1975). The percentage of surviving patients was 
21, 8.5, 3.5 and 2 after respectively I, 3, 5 and 6 years. These patients, 
however, were treated in many (59) different centres. Experience, as 
regards heart transplantatiOn, was sometimes at a minimum and the 
operations were not performed any more after the first disappointing 
results. 
Experience, as regards heart transplantation, is much wider at 
Stanford University, where 90 of the operations were performed. Up until 
August 1975 the percentage of surviving patients was: 47, 37, 27, 24 
and 20 after I, 2, 3, 4, and 5 years respectively (Schroeder eta!. 1976). 
Transplantation of the pancreas was reported 36 times. One year's 
survival with a functioning transplant was only found twice. 
Lung transplantation was also carried out 36 times up until 1975. 
The 3 patients who survived the operation longest lived 2, 6 and I 0 
months. 
Since 1963, 181 patients have undergone orthotopic liver trans-
plantation. The number of survivors was 24, 12 and 6 after I, 2 and 3 
Table !.2. Number of patients with solid organ transplants and the percentage surviving with a functioning transplant 
up to 6 years. 
organ number of % surviving patients with a functioning transplant 
patients 
1st yr. 2nd yr. 3rd yr. 4th yr. 5th yr. 6th yr. 
kidney (I) 14806 50.6 42.6 41.8 40.6 35.2 24.0 
kidney, Rotterdam (2) 91 80 69 60 
heart (3) 257 21 - 8.5 - 3.5 2 
heart, Stanford (4) 90 47 37 27 24 20 
liver, orthotopic (3) 181 13 6.6 3.3 2.2 1.1 
liver, orthotopic (5) 
Denver, 1963-1973 
(excluding patients 
with carcinoma) 43 29.3 9.3 4.7 
Denver, 1971-1973 
(excluding patients 
with carcinoma) 16 38 
Denver, biliary atreasia 20 30 
liver, heterotopic (3) 39 2.5 2.5 
pancreas (3) 36 5.5 0 
lung (3) 36 0 
References: (I) ACS/NIH 1975. (2) Lameyer 1976. (3) Bergan 1975. (4) Schroeder et al. 1976 (5) Groth and Starzl 
1973. 
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years. Four patients are still living varying from 3h to 5h years after 
the operation. In Denver, where experience in liver transplantation is 
largest, only 4.7% of the patients survived the operation 3 years, ex-
cluding those who were operated upon because of a malignancy of the 
liver. Patients operated upon from 1971-1973 however, survived in 
38% of the cases more than one year. The results in comparison with 
heart transplantats are poor. Heterotopic liver transplantations were 
performed 39 times. Only one patient lived longer than I year and this 
one was still alive with a functioning transplant 2 years after the opera-
tion (Groth 1975). What circumstances have contributed to the fact 
that the results of liver transplantations compared with those of heart 
and kidney transplantations are so poor? Several possible factors, namely 
donor selection, sensitivity to anoxia, bacterial and viral injections, 
rejection and immunosuppressive therapy, will be discussed on the 
following pages. 
4. Problems concerning liver transplantation 
a. Donor selection 
It is possible to achieve a prolonged average survival time in dogs matched 
for the major histocompatibility complex (DL-A), compared to 
"mismatched" dogs as is shown by Chavez-Peon and Malt (1971 ), Dausset 
et al. (1971 ), Chandler et al. (1972), Ranson eta!. (1974) and Lambotte 
and Westbroek (1975). Prolonged survival after orthotopic liver trans-
plantation in dogs was also obtained by Schalm et al. (! 975) (8 of the 9 
dogs lived more than 1 year), using DL-A "matched" dogs and mild 
immunosuppressive therapy (azathioprine 2 mg/kg/day). A good donor-
recipient matching on the basis of HL-A tissue antigens is however as yet 
impossible in the practice of clinical liver transplantation since there is 
not a large "recipient pool". The same problem of small recipient pools 
occurs however with heart and lung transplantation. Only blood group 
compatibility plays a part and usually a clear histo-incompatibility 
exists between donor and recipient. In cadaver kidney transplantation, a 
large recipient group is available, kept alive by haemodialysis, so that 
HL-A matching of the kidney donor and recipient becomes possible. 
European results indeed indicate that better results are obtained, when 
donor and recipient are matched, according to HI-A tissue antigens 
(Koch et a!. 1971, Parsons et al., 1975). But in America differences 
in survival between patients with good or bad matching tissue antigens 
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(serologically determined) could only recently be demonstrated, thanks 
to the analysis of very large groups of kidney transplant patients. With 
good matching (2, 3 or 4 identical tissue antigens, n = 2,025) the percen-
tage of functioning kidney transplants after I year was 8.9% higher than 
when the matching was poor (0 or I antigen the same, n = 1,535): 
respectively 53.2% and 44.3% survival (ACS/NIH 12th report Renal 
Registry Committee). It is, however, unlikely that better tissue typing 
and matching would have had much influence on the results of clinical 
liver transplantation, since until now, rejection of the liver graft was not 
the major complication causing death of the liver transplant recipients 
(Williams eta!. 1973, Starzl eta!. 1975). 
b. Sensitivity to anoxia 
From experiments with dogs, Martin (1972) concluded that both heart and 
liver are more sensitive to anoxia than the kidney. At a temperature of 
± 37 °C the liver, after 30 minutes anoxia, is so damaged that successful 
transplantation is impossible (Schalm 1968). Irreversible liver damage, 
already existing before the donor liver was inserted, has certainly 
contributed to the death of a limited number (6) of patients (Starzl 1969). 
In Denver, therefore, only livers are used which come from brain dead 
donors with a good heart, lung and liver function. In England unlike in 
America, the heart of the donor must have ceased to beat before the 
patient is certified dead (Williams et a!. 1973, Caine et a!. 1974 ). This 
means that the liver has to be preserved quickly, preferably in a simple 
way. (Schalm 1969, Caine 1972, Caine et a!. 1972, Caine eta!. 1973, 
Caine et a!. 1974, Otte et a!. 1973 a,b ). The duration of the preserva-
tion will then be 3 to 6 hours, namely until the hepatectomy in the 
recipient is completed. Simple, clinically applicable, preservation systems 
are indeed available (Schalm et a!. 1969, Caine et a!. 1972, Caine et a!. 
1974, Lie et a!. 1974) so that poor preservation does not actually con-
tribute to the poor prognosis of liver transplanted patients (Starzl 1969, 
ACS/NIH report I 1971, Williams eta!. 1973, Groth and Starzl 1973). 
c. Bacterial and viral infections 
Bacterial and viral infections form a pronounced risk for the liver trans-
plant recipient. The cause of death in 83 patients with orthotopic liver 
transplants was in 35 of them (42%) associated with bacterial infections 
(for themostpartGram-negative), and thus infection implies a considerable 
risk for patients with liver transplants (Starzl 1969, Starzl eta!. 1975, 
Murray-Lyon et a!. 1970, ACS/NIH 1971, 1972 and 1973, Williams et a!. 
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1973). In cadaver kidney- and heart transplant recipients only 30% (n = 
25,000) and 24% (n = 137) of the causes of graft failure or death were 
associated with infections (ACS/NIH 1971, E.D.T.A. combined report 
V 1974 ). The intimate contact of the donor liver via portal vein and 
biliary anastomosis with the continuous reservoir of bacteria and viruses 
present in the intestines, apparently forms an essential threat to the liver 
transplant recipient. The problems of bile duct obstruction, immuno-
suppression and graft rejection are obviously associated with these infec-
tious complications. 
C. 1 Problems of bile duct obstruction 
Problems of bile duct obstruction are seen by some (Williams et al. 1973) 
primarily as a mechanical problem. The various forms of bile duct 
anastomosis ( choledocho-en terostomy, choledocho-choledochostomy, 
cholecysto-choledochostomy and cholecysto-enterostomy with or without 
"Roux Y Loop" or gastro-enterostomy) have, however, not yet 
produced any clear solution (Starzl 1969, Starzl et al. 1973, Caine 1969, 
Williams et al. 1973 ). It is possible that choledocho-choledochostomy with 
the use of a lumen widening piasty has theoretical and practical advantages. 
The lumen widening technique offers less chance of mechanical obstruc-
tion and the advantage of an autogenous bile duct- intestines transition 
is maintained. Consequently, there is at this transition place no chance 
of rejection with obstruction and invasion of bacteria (Schalm et a!. 
1975). Others (Martineau et a!. 1972, Coleman et a!. 1973) emphasize 
the viral genesis of bile duct obstruction appearing late after liver trans-
plantation. Whatever the causes of the obstruction may be, they are all 
followed by ascending bacterial infection. Local bile duct inflammation 
with abscess formation and generalized sepsis contribute considerably to 
the mortality seen after liver transplantation. 
C. 2 Immunosuppression and graft rejection 
General suppression of resistance against viral and bacterial infections by 
means of the immunosuppressive agents used and a predisposition to 
infections on account of the bile duct anastomosis are possibly not the 
only factors which contribute to the high risk of infection after a liver 
transplantation. The liver has an extensive reticulo-endothelial system, 
that eliminates bacteria which penetrate the portal system from the 
intestines (Starzl 1969). This system of phagocytic cells, residing within 
the donor liver, also has its function suppressed by the immunosuppressive 
agents. 
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In our opinion, thought should be given to the possibility that these 
phagocytic cells are also impeded in their activity by the "Host versus 
Graft" or rejection reaction. This hypothesis is supported by the 
experiences of Starzl and co-workers (Starzl 1969 p. 327), who found 
that with insufficient immunosuppression septic hepatic infarctions 
occurred in five consecutive cases. After the immunosuppressive therapy 
was intensified, no other cases of regional hepatic gangrene with 
septicaemia were seen. 
Multiplication of bacteria to a great extent occurs during the opera-
tion and directly afterwards due to the paralytic ileus, caused by the 
abdominal operation. Penetration into the bloodstream (portal vein) and 
biliary system will be seen in many instances (Brettschneider eta!. 1968). 
If, during the time of the transplantation and directly afte, wards, 
the bacterial density in the intestines is decreased, then this should 
theoretically lead to less infections after transplantation of the liver. 
Schalm et al. (1975) indeed found few infectious complications after 
liver transplantation in dogs and pigs, in comparison with earlier 
experiments, when the quantity of intestinal bacteria was reduced for a 
period of 2 days atthe time of the liver transplantation by means of selective 
bowel decontamination. Adequate control experiments, carried out at 
the same time are however, still required. In order to reduce the chance 
of bacterial invasion from the intestines, a reduction of the number of 
bacteria might also be of importance during surgical re-explorations or 
at the time of an acute rejection of the transplanted liver. 
d. Rejection and immunosuppressive therapy - rationale for rhe 
experiments 
Originally clinical liver transplantation was carried out, after which the 
recipients were given very little or no immunosuppressive therapy (Starzl 
1969, Williams et a!. 1973, Aune 1973). This usually led to irreversible 
rejection of the liver. Just as with heart transplantation a strong immuno-
suppression will, however, be necessary in order to combat rejection ofthe 
liver. A real problem is that there are so few certain indications for 
determining an imminent rejection process (Starzl 1969, Williams et a!. 
1973, Groth and Starzl 1973 ). Neither the leucocyte migration test (an 
aspecific cellular reactivity test) nor successive liver biopsies, provide 
unequivocal information concerning the rejection process (Eddleston et 
a!. 1971, Williams et a!. 1973). Both the side effects of azathioprine 
(hepatoxicity and intrahepatic cholestasis, Starzl et a!. 1965) and bile 
duct obstruction and hepatitis may give those liver function disorders 
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which are also found in rejection of the liver: decrease in liver function 
(production t and poison-removing effect t ), liver cell loss, cholestasis, 
hyperbilirubinaemia, rise in temperature, enlargement of the liver, 
general discomfort etc. 
A!! transplantation centres use corticosteroids to prevent or treat 
rejection of the transplanted liver. Opinions on the nature and dosage of 
the additional immunosuppressive agents used, such as azathioprine, 
cyclophosphamide or Antilymphocyte Globulin (ALG) do, however, 
differ. (Starzl 1969, Lie et al. 1971, Aune et al. 1972, Fortner et a!. 
1973, Williams eta!. 1969, 1973, Groth and Starzll973). Because of 
the supposed hepatotoxicity of azathioprine, Starzl and co-workers 
have replaced this agent by cyclophosphamide, during the first three 
months after liver transplantation. However, bone marrow depression 
during therapy with cyclophosphamide (2-4 mg/kg/day) is more likely 
to occur and azathioprine may still be preferable for chronic treatment 
(Groth and Starzl 1973). Rejection episodes occur mostly within 3 
months after transplantation (Starzl 1969, Williams et al. 1973). It is 
because of this reason that, just as with heart transplantation, ALG is 
used during that period in order to suppress rejection of the liver trans-
plant most vigorously. (Groth and Starzl 1973, Schroeder eta!. 1976, 
Starzl eta!. 1975). 
The immunosuppressive treatment used in liver transplantation in 
fact is based on the experiences obtained through clinical and experi-
mental kidney transplantation. Systematic research concerning immuno-
suppressive therapy after liver transplantation is scarce. The rejection of 
a pig liver transplant is slow and not very aggressive, in contrast to 
human liver transplant rejection. The pig species is therefore not suitable 
for research concerning prevention or treatment of acute liver rejection 
(Caine eta!. 1967(a), 1967(b), Battersby eta!. 1974, Terblanche eta!. 
1968). The dog species and subhuman primate, in whom acute rejection 
of the transplanted liver occurs, have strong individual disparity of 
histocompatibility antigens, possibly also of "immune responsiveness" 
(Vriezendorp !973 ). Thus, Starzl et a!. (1965) observed survival times 
of unmodified liver transplanted dogs varying from 2 to I 0 days (n = 
22, mean survival time± s.d.: 7.1 ± 2.2 days). After azathioprine therapy 
(8 mg/kg/day tapered to 2 mg/kg/day after I week, thereafter 2-4 
mg/kg/day) they found a mean survival time of 27.9 ± !6.5 days. How-
ever, in order to compute the mean survival time, the maximal survival 
time was arbitrarily limited to 50 days post transplantation. In fact 
survival differed from I day to more than one year, 30.8% of the animals 
living for 50 days or more (see scheme below). 
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Consequently very large series of dogs would be needed in order to 
demonstrate differences in effectiveness between immunosuppressive 
regimens. 
Chandler et a!. (!972) also investigated the influence of immuno-
suppression on survival of dogs after orthotopic liver transplantation. 
They used multispecific cytotoxic allo-antisera to determine if histocom-
patibility matching would improve the survival rate. The "mistmatched" 
Beagles lived for 8.7 ± 1.2 days after operation (mean ± s.e.m.). 
"Matched" animals lived without treatment for 43.9 ± 13.7 days (arbi-
trary limit of I 00 days). However, additional treatment with azathioprine 
(2 mg/kg tapered to I mg/kg/day) or Antilymphocyte Globulin (ALG) 
(40 mg/kg/day tapered to 20 mg/kg/2 days) failed to demonstrate a 
significant prolongation of mean survival time compared to untreated 
matched animals. 
Myburgh and co-workers have chosen the monkey (Baboon) as 
their experimental animal for orthotopic liver transplantation. They 
first demonstrated the acute course of the liver rejection in these animals. 
Of 12 monkeys with an orthotopic liver transplant, 75% died within two 
weeks, the other animals lived up until 36 days (mean ± s.e.m.: 12.9 ± 
2.5 days). Prolongation of survival time of several animals could be 
observed, when treated with Antilymphocyte Globulin (ALG), azathio-
prine, prednisolone or combinations of these agents. However, no 
significant difference in survival time could be demonstrated after 50 days 
between treated and untreated animals (My burgh et a!. 1971 ). Further 
experiments were directed towards obtaining "tolerance and enhance-
ment" effects, using for instance donor bone marrow cells and alloim-
mune antisera. Thus, using sera obtained from I 0 baboons after their 
immunisation with allogeneic lymphoid tissue, together with bone 
marrow cells, a significant prolongation could be obtained. (Mean 
survival time ± s.e.m.: 50.9 ± 7.6 days, 6 out of I 0 animals being alive 
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after 50 days) (Myburgh and Smith 1972). Subsequent experiments 
demonstrated, just as with dogs a pronounced variation of survival 
time in the treated animals (Smit and Myburgh 1974, Little et a!. 1975 
and Myburgh and Smith 1975). 
Rats, like dogs and monkeys, also have acute rejection of allogeneic 
liver transplants. Their use for liver transplantation experiments, would 
have several advantages compared to those with larger experimental 
animals. 
The financial aspects plays a significant role, since the total costs 
of breeding, care and accommodation before, during and after the 
operation are much less in rodents. One problem however is, the micro-
surgical operative technique needed to transplant the liver in these small 
animals. 
A second important factor is that inbred strains can be obtained easily. 
Since antigenic properties within one inbred rat species are equalinallmem-
bers of that species, the differences between two inbred rat species are 
constant. It is therefore likely that less individual variation between the 
rejection patterns will occur. The anatomic differences within one inbred 
strain of rats are less pronounced than in dogs or monkeys, consequently 
there will be less individual differences in the operative procedure com-
pared to larger animals. 
A suitable auxiliary technique for liver transplantation, in which 
the recipient liver still sustains the life of the animal, did not exist, 
let alone a non-auxiliary liver transplantation technique, in which no 
functional recipient liver tissue would be left at the time of transplan-
tation. This last technique in fact would be needed when different 
immunosuppressive regimens were to be compared and results of liver 
function tests were to be used as parameters for the function of the 
transplanted liver. 
The purpose of the investigations described below, were: 
-to develop an auxiliary technique of liver transplantation in the rat, in 
order to obtain better survival figures; 
-to develop a non-auxiliary technique of liver transplantation in the rat; 
-to investigate the acute unmodified rejection pattern after allogeneic 
livertransplantation, through serial liver function tests and histology; 
- to evaluate the efficacy of some short term immunosuppressive 
regimens upon the modification of acute liver transplant rejection, 
while the histocompatibility differences between donor and host were 
controlled through the use of inbred rat strains. 
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Chapter II 
HETEROTOPIC AUXILIARY LIVER TRANSPLANTATION IN RATS 
The following chapter is reproduced by permission of the Williams and 
Wilkins Company, Baltimore. It was published before in Transplantation 
Vol. 12, pages 415420 in 1971. Authors: Kort, W.J., Wolff, E.D. and 
Eastham, W.N. 
SUMMARY 
Heterotopic auxiliary liver transplantation in rats was performed with a 
portal afferent blood supply, together with either the infra- or suprahepatic 
part of the inferior vena cava (IVC) as the efferent vessel. Animals in 
which the suprahepatic part of the IVC was used had a high postopera-
tive mortality which was associated with moderate or severe congestion 
of the graft in over one-half of the cases. Substitution of the intrahepatic 
part of the IVC prevented the congestion and increased the postoperative 
survival rate. 
I. Introduction 
Experimental liver transplantation has been performed in different 
animal species. Among the animals which have been used are monkeys 
(1), pigs (2), dogs (11), and rats (4, 5). Lee's original technique of auxi-
liary liver transplantation in rats consists of a 30% liver graft receiving its 
afferent blood supply from the coeliac axis, with the suprahepatic part 
of the IVC serving as the efferent vessel. The common bile duct, portal 
vein, and infrahepatic IVC are ligated. 
We used this method in a pilot experiment in which 22 rats were 
given liver transplants. Extreme congestion of the grafted liver occurred 
in 12 of the 16 animals which survived the operation but which died 
within 24 hr. Thrombotic occlusion of the coeliac axis was present in the 
remaining four. These findings sggest that the principal factor responsible 
for the failure of this technique in our hands was an impaired hepatic 
outflow. For this reason, we modified the technique by substituting the 
infrahepatic part of the IVC for the suprahepatic part. Although an 
inadequate blood flow through the coeliac artery probably contributed 
to only one-third of the deaths, we also decided to change to a portal 
blood supply, as this source is known to contribute approximately 80% 
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of the blood flow through the liver and to provide, on the average, 70% 
of the available oxygen (12). 
In order to evaluate the effectiveness of the modified operative 
procedure, comparative studies were performed in which either the 
infra- or suprahepatic parts of the IVC were used in combination with 
a portal blood supply. 
2. Material and methods 
Animals 
Forty inbred, specific pathogen-free female rats of either the Wag/Rij or 
BN/Bi strain, weighing 150-200 g, were used as donors. Forty males of 
the same strains, weighing 300-350 g, served as recipients. 
Experimental Procedure 
Nineteen animals received liver transplants with an infrahepatic outflow, 
and 21 received liver transplants with a suprahepatic outflow. All those 
animals which were operated upon but which failed to recover from the 
anaesthetic were designated as having had an operative death. The differ-
ent operative procedures were performed on donor-recipient 
;ombinations, Wag/Rij -+ Wag/Rij, BN/Bi -+ Wag/Rij, BN/Bi ...; BN/Bi, 
and were repeated until five animals from each of the combinations 
survived the operation. The different operative methods were performed 
in the sequence indicated by the operation numbers listed in Tables 1-3. 
Infrahepatic IVC Method 
Isolation and perfusion of donor livers. To reduce respiratory 
tract secretions, donor as well as recipient animals were given 0.01 mg of 
atropine s.c. 20 min before being anaesthetised with ether. Following 
exposure of the donor's IVC, 0.5 mg/kg of heparin (Leo) in 0.5 ml of 
physiological saline was injected into that vessel. A 70% hepatectomy 
was performed according to the method used by Higgins and Anderson 
(3), and the common bile duct was ligated close to the liver hilus. Heparin 
(2.5 mg/kg in 1.0 ml of saline) was then injected directly into the portal 
vein before it was cannulated with a Braun i.v. catheter (1.0 x 1.5 mm ¢). 
The hepatic artery was isolated and a loose tie was placed around it near 
the liver hilus. The thorax was then opened, the suprahepatic part of the 
IVC was ligated above the diaphragm, and the infrahepatic IVC was cut 
transversely and proximal to the right renal vein. The hepatic artery was 
ligated and divided. The liver was then freed from surrounding tissue and 
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was removed with a large piece of attached diaphragm. After isolating 
the graft, we perfused it through the portal vein with cold saline ( 4 °C) at 
a rate of 20 drops/min and at a pressure of 20 em H2 0 until transferring 
it to the host. During this interval, which lasted about I 0 min, the liver 
was immersed in cold saline at 4 °C and was perfused by a total of± I 0 
ml of perfusate (Fig. I). 
Figure I. Heterotopic auxiliary rat liver transplantation using the infrahepatic vena 
cava as the efferent vessel. The donor's suprahepatic IVC, hepatic artery, and 
common bile duct and the host's right renal vein all are ligated. 
Transplantation technique. After receiving ether anaesthesia, 
recipient animals were given 0.5 mg/kg of heparin into a lateral tail 
vein. The operative procedures were performed under clean but non-
sterile conditions, and the contents of the peritoneal cavity were inter-
mittently moistened with saline. Hepatectomy (removing only 70% of 
the liver), together with right nephrectomy, was performed through a 
midline abdominal incision. The vena cava was freed from perivascular 
tissue proximal to the ligated right renal vein. The portal vein was 
separated from the hepatic artery by blunt dissection, and a loose liga-
ture (4/0 silk) was placed around it. A section of the wall of the vena 
cava, proximal to the ligated right renal vein, was then isolated in a 
Satinsky-like curved arterial clamp, and an oval aperture was cut in it 
with iris scissors. The graft was removed from the cold saline and placed 
in the right side of the abdomen, and an end to side anastomosis of the 
infrahepatic IVC was made with the clamped part of the host vena cava 
(continuous sutures; 7/0 silk; Ethicon). 
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The loose ligature, previously placed around the recipients portal 
vein, was then tightened, prior to cutting of the vessel. The two portal 
veins were joined by end to end anastomosis (continuous sutures; 7/0 
silk; Ethicon) during which time(± I 0 min) the host vessel was occluded 
by a bulldog vascular clamp. The donor liver was lifted toward the 
recipient's portal vein by placing a saline-soaked dental pack beneath it. 
We restored the circulation through the graft by releasing the caval and 
portal vascular clamps, in that order. In order to compensate for blood 
loss, each animal received I ml of saline i.v. We stabilised the position of 
the graft by stitching the attached diaphragm to the lateral abdominal 
wall and retroperitoneal fat with three separate sutures of 4/0 silk. The 
intestines were replaced, the abdominal wound was sutured with con-
tinuous catgut, and the skin was closed with autoclips. 
Suprahepatic IVC Method 
Isolation and perfusion of donor livers. This procedure was 
essentially the same as that previously described, with the following 
exceptions. Instead of ligating the suprahepatic part of the IVC, we 
resected this vessel, together with a rim of right atrial tissue, after which 
we ligated the infrahepatic IVC (Fig. 2). 
Figure 2. Heterotopic auxiliary rat liver transplantation using the suprahepatic vena 
cava as the efferent vessel. The donor's infrahepatic NC, hepatic artery, and 
common bile duct and the host's right renal vein all are ligated. 
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Transplantation technique. The operative procedure varied 
only in that the suprahepatic part of the IVC was anastomosed to the 
host's vena cava. The methods of anastomosis were the same as those 
employed in the infrahepatic IVC method. 
Postoperative Care 
Immediately after operation, the animals were placed under an infrared 
light for 2-3 hr, and 50,000 international units of penicillin G/kg and 50 
mg of streptomycin/kg were injected i.m. During this time and for the 
following 24 hr, the rats were given a drinking bottle containing 5% 
glucose, after which they were given their preoperative diet of acidified 
water and food pellets. The antibiotic therapy was repeated on the next 
day. 
Evaluation of the Transplanted Liver 
Animals dying on day I died within 24 hr of the operation. Subsequent-
ly, the designated day of death corresponds to death within the 
equivalent number of 24-hr periods. All animals in the pilot series died 
within 3 days and, therefore, survival for 4 days in the present series was 
taken as an indication of successful vascularisation of the graft. There-
after, animals were examined under ether anaesthesia, and the organs 
were removed for histological evaluation. Animals with allogeneic grafts 
were killed on day 5, so that developing changes attributable to rejec-
tion would not obscure the appearance of the transplanted liver. 
Isogeneic grafted animals were killed on days 7, 8 and 9. Necrbpsy was 
performed on those animals which died spontaneously. The tissues were 
fixed in 4% buffered formalin and 5-!1 paraffin-embedded sections were 
stained with hematoxylin, azophloxin, and saffron. 
Congestion, when observed in the donated livers, was graded as 
being of a mild (+),moderate (++),or severe (+++)degree. Donor livers 
without congestion were graded as (-). 
3. Results 
In addition to the observations listed in Tables 1-3, bile duct prolifera-
tion was noted in both isogeneic and allogeneic transplanted livers of 
animals surviving for 4 days or more. Changes attributed to rejection of 
the graft (periportal mononuclear cellular infiltration) were observed in 
allogeneic transplanted livers. 
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Table 1. Survival and pathological findings of BN/Bi-+ BN/Bi liver-transplanted rats 
with a supra- or infrahepatic outflow 
Op-
era 
tion 
No. 
2 
3 
4 
5 
6 
7 
8 
2I 
22 
23 
24 
29 
30 
32 
33 
36 
Day 
and 
mode 
of 
death" 
I; t 
• 
* 
* 
* 
* 
* 
* 
2;t 
7;t 
I; t 
7;k 
I; t 
7;k 
7;k 
7;k 
5;t 
Type 
of 
opera-
tion6 
SUP 
SUP 
SUP 
SUP 
SUP 
SUP 
INF 
INF 
SUP 
SUP 
SUP 
INF 
SUP 
INF 
INF 
INF 
INF 
Degree 
of con-
gestion 
in 
donated 
liverc 
+++ 
+++ 
+ 
+ 
++ 
Relevant pathological 
data and/or cause 
of death 
Severe congestion with necrosis of 
donor liver; congestion of spleen 
and intestines 
Unsuccessful portal anastomosis 
Respiratory failure 
Unsuccessful portal anastomosis 
Severe congestion of donor liver, 
portal vein, and intestines; circula-
tory failure 
Tom suprahepatic IVC 
Unsuccessful portal anastomosis 
Unsuccessful portal anastomosis 
Severe congestion with necrosis of 
donor liver; congestion of spleen 
and intestines 
Icterus attributable to biliary ob-
struction; multiple haemorrhages 
Severe congestion and necrosis of the 
butterfly lobe; centrizonal necrosis 
of host liver 
Icterus attributable to biliary 
obstruction 
Congestion and early necrotic 
changes in donor liver; centrizonal 
necrosis of host liver 
No significant pathological findings 
No significant pathological findings 
Icterus with intestinal haemorrhages; 
centrizonal necrosis of host liver 
Diffuse fatty change in both donor 
and host livers 
a *, operative death; t, spontaneous death; k, killed under anaesthesia. 
b INF, infrahepatic part of the IVC used as the efferent vessel; SUP, suprahepatic part of the 
fVC used as the efferent vessel. 
c See Materials and Methods for explanation. 
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Table 2. Survival and pathological fmdings of BN/Bi-+ Wag/Rij liver-transplanted rats 
with a supra~ or infrahepatic outflow 
Op-
era 
tion 
No. 
16 
17 
18 
19 
20 
25 
26 
27 
28 
31 
Day 
and 
mode 
of 
death" 
3;t 
3;t 
2;t 
I; t 
I; t 
S;k 
S;k 
S;k 
I; t 
S;t 
Type 
of 
ope raM 
tionb 
INF 
INF 
SUP 
SUP 
SUP 
INF 
INF 
SUP 
SUP 
INF 
Degree 
of con~ 
gestion 
in 
donated 
liverc 
+ 
++ 
++ 
+ 
++ 
Relevant pathological 
data and/or cause 
of death 
Peritonitis 
Hydrothorax and (?) septicaemia 
Centrizonal necrosis of host liver; 
solitary, small pulmonary throm-
boembolus 
Congestion of donor liver and in-
testines with blood in the peritoneal 
cavity 
Congestion of intestines with intes-
tinal haemorrhage 
No significant pathological findings 
No significant pathological findings 
Centrizonal necrosis of host liver 
Thrombosis in and possible occlus-
sion of the thoracic part of the VIC 
with haemorrhage into the perito-
neal cavity; centrizonal necrosis of 
host liver 
No significant pathological findings 
a *, operative death; t, spontaneous death; k, killed under anaesthesia. 
b lNF, infrahepatic part of the IVC used as the efferent vessel; SUP, suprahepatic part of the 
IVC used as the efferent vessel. 
c See Materials and Methods for explanation. 
4. Discussion 
Examination of the tabulated results reveals an increased 4-day post-
operative mortality in those animals in which the suprahepatic part of 
the IVC was used as the efferent vessel (II of a total of 13 animals 
dying within this period). Although the grafted livers in these II animals 
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Table 3. Survival and pathological fmdings of Wag/Rij -+ Wag/Rij liver-transplanted 
rats with a supra- or infrahepatic outflow 
Op-
era 
tion 
No. 
9 
lO 
I! 
12 
13 
14 
15 
34 
35 
37 
38 
39 
40 
Day 
and 
mode 
of 
death a 
9;k 
9;k 
* 
* 
9;k 
8;k 
8;k 
8;k 
l; t 
2;t 
* 
2;t 
5;t 
Type 
of 
opera-
tionb 
INF 
!NF 
INF 
INF 
INF 
!NF 
!NF 
SUP 
SUP 
SUP 
SUP 
SUP 
SUP 
Degree 
of con-
gestion 
in 
donated 
liverc 
+ 
+ 
Relevant pathological 
data and/or cause 
of death 
No significant pathological findings 
No significant pathological findings 
Unsuccessful portal anastomosis 
Unsuccessful portal anastomosis 
No significant pathological findings 
No significant pathological findings 
No significant pathological findings 
No significant pathological findings 
Extreme congestion of host liver 
with early degenerative changes in 
donor liver 
Peritonitis, ascites, hydrothorax, and 
pulmonary congestion 
Unsuccessful portal anastomosis 
Ascites, hydrothorax, and pulmonary 
congestion 
Peritonitis 
a *,operative death; t, spontaneous death; k, killed under anaesthesia. 
b INF, infrahepatic part of the IVC used as the efferent vessel; SUP, suprahepatic part of the 
IVC used as the efferent vessel. 
c See Materials and Methods for explanation. 
acquired a normal colour after the vascular clamps had been released, 
they subsequently became swollen and progressively darker, despite a 
detectable outflow in the efferent vessel. At necropsy, 6 animals had 
moderate or severe congestion of the liver. This sequence of events was 
particularly evident in animal No. 5, in which circulation through the 
graft eventually stopped, resulting in an operative death. 
It is doubtful that intrahepatic outflow block, of the type described 
by Starzl et al. (10) and Schalm et al. (8) in dogs, played a significant 
role in our series, as the congestive changes were never seen at operation 
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when the infrahepatic part of the IVC was used as the efferent vessel. 
When the suprahepatic part of the IVC is used as the vascular out-
let for the graft, the length and position of this vessel render it particu-
larly susceptible to stretching and torsion, especially when the animal 
assumes its normal walking position. At such a time, the grafted liver is 
at least partly supported by the vessel which is then situated directly 
beneath it. Any compression suffered by the vessel in this position may 
also be compounded by the presence of mobile or distended intestinal 
loops corning to lie between the vessel and the abdominal wall. Kinking 
of the vein is also possible, this having been previously recorded in pig 
liver transplants (6, 7). The possibility that spasm of the vessel may be 
significant is unlikely, as the wall of the suprehepatic IVC is virtually 
devoid of muscle cells. The importance of the contractions of the atrial 
patch, which often continues to beat independently and for some time 
after the anastomosis is completed, is difficult to assess. 
When the infrahepatic part of the IVC is used as the outlet, the 
opportunity for any of these factors to become operative is greatly 
lessened. In the tlrst instance, the length of the outflow vessel is very 
much shorter (2 rnrn), so that kinking and torsion are virtually impossi-
ble, and blood leaving the liver enters the host's IVC almost immediately. 
Second, the site of the infrahepatic part of the IVC and its anastomosis 
is surrounded by the donor liver and, therefore, protected from any 
possible compression. Third, if vascular spasm does play a part in the 
suprahepatic method, it is less likely to occur in the infrahepatic IVC 
which is, to some extent, held open by its intimate associations with the 
liver parenchyma on the one hand and the suture line of the anastomosis 
on the other. 
It is evident from Table 3 that, although the 4-day postoperative 
mortality rate was also high in Wag/Rij animals with suprahepatica IVC 
efferent vessels, significant congestion of these isogeneic liver grafts were 
not encountered. We do not have an adequate explanation for this obser-
vation, particularly when one considers that the diameters of the anasto-
mosing vessels of the Wag/Rij female donors were much smaller 
(approximately one-half) than those of their BN/Bi counterparts. This 
also made the isogeneic Wag/Rij transplantations technically more difficult. 
In two animals (Nos. I 7 and 23), severe congestion occurred in the 
caudate lobe of the donated liver, while the remainder of the graft was 
only mildly congested. The particular anatomical features of this part of 
the liver have led us to refer to it as the "butterfly lobe". In the normal 
situation, the "wings" of this lobe ernbrance the stomach and are partly 
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supported by it and by the gastrohepatic ligaments. However, after 
transfer of the graft to the host, the butterfly lobe loses these points of 
support, and it is then sometimes difficult to position this part of the 
graft satisfactorily. When encountered, this problem appears to be un-
related to the method employed for efferent vessel anastomosis and is 
simply the result of obstruction of a lobular vascular pedicle. 
A similar situation in a human subject was described by Starzl et 
a!. (9) in which the arterial supply to a lobe was impaired. Should 
positioning of the butterfly lobe prove troublesome and should its 
vascularization appear to be jeopardised, it can be removed without ad-
versely affecting the remainder of the graft. 
Centrizonal necrosis of the remaining host liver was observed in 6 
recipients. Three of these were of the BN/Bi strain and 3 were Wag/Rij 
animals. All had been given BN/Bi liver grafts and, with the exception 
of I animal, the suprahepatic IVC method had been employed. Of these 
animals, 3 died within 24 hr, l died within 2 days, and the 5th and 6th 
survived the 4-day postoperative period. Therefore, it appears that, when 
the suprehepatic part of the IVC is used, there is an increased risk, not 
only of inducing extrahepatic outflow obstruction but also of precipi-
tating centrizonal necrosis in the remaining host liver. 
If the operations are viewed chronologically, it is obvious that in 
the early stages of the series there was a very high operative mortality. 
This result is readily explained on the basis of inexperience with the end 
to end porta-portal anastomosis and, once this was overcome, the oper-
ative mortality dropped to almost zero. The average operation time was 
I hr, including the 15 min required for isolating the donor liver. 
Portacaval shunted rats can survive 70% hepatectomy and, there-
fore, the auxiliary transplantation procedure does not completely elimi-
nate the functional capability of the residual host liver. Nevertheless, an 
accelerated decrease in host liver function can be achieved by ligating the 
common bile duct. In these circumstances, and especially if a longer 
period of survival is desired, it becomes necessary to implant the donor's 
common duct into the duodenum. Our subsequent experience has shown 
that such a manoeuvre is in no way hindered when the described method 
of hepatic transplantation is adopted. 
We concluded that, in this series of heterotopic auxiliary rat liver 
transplants in which small female rats were used as donors, the utilisation 
of the infrahepatic part of the IVC as the efferent vessel prevented 
congestion of the graft and resulted in an improved 4-day postoperative 
survival rate. 
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Chapter III 
NON-AUXILIARY LIVER TRANSPLANTATION IN THE RAT 
I . Introduction 
Immunological mechanisms of liver transplant rejection and its functional 
consequences have been studied in a number of animal species (Caine et 
a!. 1967 (b), Caine eta!. 1970, Lee and Edgington 1968, Myburgh eta!. 
I 971, Slapak et al. 1970, Starzl et a!. I 965). The use of rats is advanta-
geous in two ways, first because genetic factors are controlled by the use 
of inbred strains and secondly, costs are limited compared to the use of 
dogs, pigs or monkeys. 
Lee and Edgington (I 968) first reported on histopathological 
changes of allogeneic liver transplants in rats. Fisher and Fisher (1970) 
further characterised these changes and in addition performed ultra-
structural studies. Histochemical investigations have been performed by 
Jerusalem eta!. (1971) and Jap (1972, Jap eta!. 1972). However, all 
these studies were performed on auxiliary liver transplants, leaving a life-
sustaining part of liver in the recipient, together with the transplanted 
liver. This leads to a complicated situation: for instance "functional 
competition" (Hess eta!. I 972, v.d. Heyde 1966, Schalm I 966) between 
host and donor liver, causing atrophy of the graft, may obscure the 
immunological processes involved in the rejection of the graft (Marchi oro 
et a!. I 965). Another important non-immunological factor is the difficul-
ty in interpretation of the biochemical results when two livers are 
present in the recipient. 
We therefore decided to develop a non-auxiliary transplantation 
technique in the rat. The animals were allowed to live for 7 weeks since this 
observation period would permit the evaluation of the majority of the 
liverallograft rejection crises. Also when immunosuppression would 
subsequently be used (see chapter IV), it could be expected that as with 
kidney transplantation experiments, acute rejection of the liver was to 
occur within this period (de Bruin I 970, Tin bergen I 972). 
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2. Material and Methods 
a Animals 
Inbred, specific pathogen free* female BN/Bi rats weighing 150 - 200 g 
were used as donors. Male animals of the same strain or inbred Wag/Rij 
males both weighing 300 - 350 g served as recipients, for isogeneic and 
allogeneic transplants, respectively. The complete female donor livers 
were heterotopically transplanted into hepatectomised male recipients. 
Mean donor liver weight was 6.08 ± 0.50 g, while male BN livers weighed 
8.70 ± 0.55 g and male Wag livers weighed 9.58 ± 0.62 g, 39 isogeneic 
and 38 allogeneic transplantations were performed. 
b Surgical technique 
Isolation and perfusion of donor livers is essentially as described 
before (chapter II) but instead of performing partial hepatectomy, the 
donor liver is kept intact. After ether anaesthesia atropine 0.01 mg 
together with heparin 50 I.U. (Leo) in 1.0 ml of saline is injected into the 
exposed I.V.C. The whole donor liver with its infrahepatic I.V.C., 
common bile duct, canulated portal vein, diaphragm and ligated supra-
hepatic I.V.C. is dissected from surrounding tissues and immersed in 
cold saline ( 4 ° C). Portal vein perfusion is performed at a rate of 5 drops/3 
minutes, pressure l 0 em H2 0, while a total volume of 3 ml perfusate is 
used. 
Hepatectomy and insertion of the donor liver (see Fig. Ill l). 
Under ether anaeasthesia recipient animals receive 0.01 mg of ,atropine 
and I 0 I.U. of heparin in 0.5 ml saline I.V. Through a midline abdominal 
incision the procedure is started with only a 70% hepatectomy. Right 
nephrectomy and separation of the portal vein is performed thereafter. 
Recipient hepatectomy is continued with removal of the posterior part of 
the right lateral lobe, after ligation of its pedicle with a single ligature 
(2/0 slik). The inferior vena cava is isolated in a curved arterial clamp, 
the graft is transferred to the right side of the recipient's abdomen and 
an end-to-side anastomosis of the donor's infrahepatic I.V.C. is made 
with the host's vena cava, proximal to the ligated right renal vein. 
The administration of ether is interrupted while the end-to-end anastomo-
sis between the portal veins is made. Both anastomoses are made with 
continuous sutures using 7/0 silk; following their completion the caval 
*Free from Salmonella, Pasteurella and pleuroNpneumonia like organisms. 
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and portal clamps are released and ether is then given again. Saline (I ml) 
is given I.V. to compensate for possible blood loss (usually not more 
than Y, ml). Total anoxia time of the liver transplant was ± 40 minutes. 
The host's hepatic artery and common bile duct are double ligated and 
cut. The caudate lobe is exposed after dissection of its ligaments, ligated 
around its pedicle with 2/0 silk and removed. Recipient hepatectomy is 
now completed by removal of the superior part of the right lateral lobe, 
in the same way, as near as possible to the I.V.C. Hemostasis occurs 
usually spontaneously due to the discontinuation of portal and arterial 
blood flow. The duodenum is approximated towards the donor liver and 
the smallest possible length of common bile duct implanted into the 
duodenum and fixed with 7/0 silk to the wall. The intestines are placed 
evenly within the abdominal cavity. The peritoneum and abdominal wall 
are closed with catgut, the skin with autoclips. A transfusion consisting 
of I ml isologous blood with 1.5 ml 5% glucose is given I.V. Recipient 
operation took approximately 60 minutes. Afterwards animals are 
warmed and provided with a drinking bottle with 5% glucose in the 
drinking water for 24 hours. Acidified water and commercial food 
pellets were provided ad libitum to the individually caged animals 
thereafter. 
Antibiotic trea tm en t. Penicillin, Streptomycin and Cephaloridin 
were given s.c., daily during three weeks after the operation, in doses of 
10.000 I.U., 10 mg and 20 mg respectively. 
c Laboratory techniques and experimental design 
Body weight, hematocrit, clotting activity and biochemical deter-
minations were performed twice a week during the two weeks following 
transplantation and once a week thereafter. Bromsulphtalein (B.S.P.) 
retention was determined once a week. Blood from animals under ether 
anaesthesia was obtained by retro-orbital sinus puncture using a non 
heparinised glass capillary, wetted with 5 1'1 sodium citrate. The first 
two drops were discarded to obviate possible clotting activation by 
tissue thromboplastin or overdosage of the sodium citrate. 0.8 ml of 
blood was collected in polyethelene micro reaction flasks (Eppendorf) 
containing 20 1'1 sodium citrate 0.55 mol and immediately mixed (Whirl-
mix Vortex). Blood samples were centrifuged for one minute (12000 g 
Eppendorf Microcentrifuge) and the supernatant plasma collected in 
polystirol crystal tubes with polyethene caps (Emnosa Belgium). All 
plasma samples and their dilutions were kept on melting ice until used. 
Diluant was barbital sodium acetate buffer pH 7.4, as described by 
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Michaelis (1930). One heparinised capillary (0.08 ml) was used to deter-
mine haematocrit values. 
Fig. III 1. Schematic representation of liver transplantation in the rat. 
The recipient is fully hepatectomized, the bile duct and hepatic artery are ligated. The portal 
vein is diverted to the heterotopically placed liver transplant. Efferent blood flow goes through 
the infrahepatic inferior vena cava. The donors hepatic artery and suprahepatic inferior vena cava 
are ligated. 
Prothrombin activity was determined according to the one stage 
principle (Owren, 1949). Prothrombin deficient rat plasma was prepared 
according to Koller et al. (1951 ). Citra ted rat plasma was absorbed with 
aluminium hydroxide to obtain rat plasma, free of Prothrombin, Factors 
VII, IX and X. This plasma was mixed with rat serum in a ratio of 2 : I. 
The resulting prothrombin deficient rat plasma contained 1.4% Pro-
thrombin (F ll), 41 mg% Fibrinogen (F I), 71% F V and> 100% F VII. 
At intervals of 30 seconds, 0.050 ml of each of the following 4 specimen 
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were successively added to a glass tube, and maintained at 37 •c in a 
water bath: 
I. the test sample (diluted I : I 0) 
2. rat plasma deficient in Prothrombin 
3. rat Thromboplastin (3 7 °C) 
4. calcium chloride (0.033 mol, 3 7 •c). 
The constituents were vigorously mixed after each successive addition. 
Coagulation time (time from recalcifation until formation of a fine fibrin 
thread) was recorded by repeatedly drawing a "Kolle" hook through the 
mixture. Prothrombin activity was expressed as % of normal after com-
parison with a time-concentration curve made with pooled normal rat 
plasma (fig. Ill 2). 
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Fig. III 2. Rat prothrombin time-concentration graph. 
Each dot represents the mean time of five clotting time measurements using a certain dilution of 
pooled rat plasma mixed with prothrombin deficient plasma, thromboplastin and calcium 
chloride (see text). The "0" point of plasma concentration is obtained by successively adding the 
herefore mentioned constituents to Michaelis buffer instead of pooled rat plasma. 
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Normotest® which can determine on a percentage ratio the presence 
or absence of the liver synthetised clotting factors II, VII and X were 
performed (v. Oosterom and Veltkamp 1974). Because of the sensitivity 
of Thrombotest® for the endogenous clotting antagonist P.I.V.K.A. 
(Protein Induced by Vitamin K Absence or Antagonist), this test was 
used in order to distinguish vitamin K deficiency (II, 34 ). Thrombotest 
and Normotest reagents (kindly provided by Nyegard, Oslo) were 
prepared with 3.2 mmol calcium chloride and distilled water respectively. 
Aliquots of 0.25 ml were stored ( -25 °C) in small glass tubes, tightly 
closed with rubber caps. The test sample of plasma (0.050 ml diluted 
I : I 0) was added to the reagent (3 7 °C), and vigorously mixed. 
Coagulation time was determined with a Kolle hook, and activities 
expressed as % of normal (compared to time-dilution curves made with 
pooled normal rat plasma). 
Plasma a! bumin was determined with a dye binding method (Hydroxy-
Benzeneazo-Benzoic-Acid: H.A.B.A.) according to De Leeuw-Israel eta!. 
(1967). 
S. G. P. T. was determined with a colorimeter according to Reitman and 
Frankel (1957), (Boehringer biochemical test combination). 
Total- and conjugated-bilirubin were measured colorometrically 
(Hollander eta!. 1968, Boehringer). 
B.S.P. retention test was performed with animals under ether 
anaesthesia, after being warmed under an infrared light to stimulate 
peripheral circulation. The dye (40 mg/ml, 0.35 ml per rat) was injected 
into a lateral tail vein and blood collected from the tail tip in heparinised 
capillaries exactly I, I 0, 20, and 30 minutes thereafter. The supernatant 
plasma (20 ~til was added to 1.5 ml 0.5 mol NaOH in 0.9% NaCI and the 
extinction determined on a colorimeter at 579 nm. 
Portal vein radiography was performed under ether anaesthesia 
at seven weeks; Urografin 76% (0.3 ml) was injected into the spleen and/ 
or a canulated mesenteric vein. 
Thereafter the relevant organs were removed for histological exam-
ination. Necropsy on the animals which died spontaneously was 
performed within 15 hours after their death. The tissues were fixed in 
4% buffered formalin and 5~t Paraffin embedded sections were routinely 
stained with hematoxylin, azofloxin and saffron (HAS). 
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3. Results 
Total time required for the transplantation was about 75 minutes. Reci-
pient operation lasted I hour, the liver transplant was ischaemic for 40 
minutes, including 20 minutes of saline perfusion. Death during the 
operation (animals not recovering from the anaesthetic) occurred in 16 
cases (20.8%) of the 77 attempted transplantations. Death within 48 
hours of the operation, occurred 30 times of the first 57 transplanta-
tions, equally devided over iso- and alia-transplanted animals. There-
after some alterations in the transplantation procedure were effectuated, 
and death within 48 hours occurred only once among the following 20 
transplantations (see discussion). Overdoses of ether, during the obser-
vation period, resulted in the death of 2 allo- and I isografted animals. 
In 4 isogeneic transplanted animals unsuccessful biliary anastomosis gave 
rise to abundant bile stained ascites, progressive hyperbilirubinaemia and 
death, between 2 and 4 weeks after transplantation. They were therefore 
considered to be technical failures and excluded from the experiment. 
The functional, histopathological and roentgenographic studies were 
performed on the remaining 13 animals with allogeneic transplants and 9 
animals with isogeneic transplanted livers. 
a Isogeneic transplantations 
All 9 animals recovered remarkably well after the operation and con-
tinued to be clinically well during the 7 weeks observation period (fig. 
Ill. 3 ). The mean maximal weight loss was 9.6% of preoperative values 
but the animals gained weight until the mean value was I 00% of the 
preoperative values (fig. III 3 ). 
Haematocrit values (fig. !II 3) rose steadily from 35.2% imme-
diately after the transplantation to 40% at seven weeks, notwithstanding 
the weekly withdrawal of l Y2 ml of blood. 
Five animals were transiently jaundiced, maximal bilirubin being 
2.6 mg/100 rnl (fig. III 4). The mean BSP uptake by the transplanted 
liver as indicated by the 1-10 minute serum excretion was within normal 
limits and in some cases even higher than normal (60% 1-10 min. 
excretion) values were reached. Excretory capacity of the liver (BSP 
20-30 min. excretion) was also normal (fig. 1!14 ). 
Four of the nine animals had elevated SGPT levels(> 50 mU/ml) 3 
days after transplantation, but only two animals at maximum had 
elevated SGPT values thereafter (fig. III 4 ). 
Albumin levels were decreased but tended to recover: 2.6 gr/100 ml 
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Fig. III 3. General parameters. 
Survival of rats bearing liver isografts or liver allografts. Mean survival time after liver allotrans-
plantation: 1 L9 days. Mean body weight and hematocrit ± s.d. of rats bearing liver isografts or 
liver allografts. 
after seven weeks (normal 3.0 gr/100 ml) (fig. Ill 5). All clotting tests: 
prothrombin, Thrombotest® and Normotest® activity normalised or 
values slightly above I 00% were obtained (fig. III 5). 
Evaluation of the radiographs, made just before the end of the 
experiment, showed normal splenoportograms. The portal veins were of 
normal caliber and the intrahepatic branches were undistorted (fig. III 
6a). The sinusoidal filling in the hepatogram phase was normal (fig. III 
6b ). Portal-systemic venous shunts, indicative of portosplenic hyperten-
sion, through collateral veins like the coronary vein, left adrenal or renal 
veins were not observed. 
At autopsy the macroscopic aspect of intestines, kidney, adrenal 
and testes was normal. The spleen and splanchnous veins were not en-
larged or dilated. The autologous liver remnant could not be found or a 
necrotic, encapsulated remainder of 0.4 gr at the most was located near the 
subdiaphragmatic part of the caval vein. The donor livers were, com-
pared to their mass at the time of transplantation, enlarged (mean 11.4 
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Fig. III 4. Excretory capacity and cell loss. 
Mean B.S.P. excretion ± s.d. in rats bearing liver transplants. 1-10 min. excretion represents 
maximal capacity of the liver to take up B.S.P. from the blood into the livercell; while the 20-30 
min. excretion represents the capacity of the liver to excrete B.S.P. from the livercell into the 
biliary system. The normal range of B.S.P.l-10 min. excretion± s.d. is indicated by the shaded 
area. 
Number of animals, bearing liver transplants, with bilirubin;:;;;.- 0,5 mg/100 ml and with signifi-
cantly raised S .G .P .T. values(~ 50 mU/1). 
± 2.5 gr S.D.). Their surface had a normal smooth aspect, the colour 
being a normal red-brown. When cut, the consistency was normal and no 
congestion of blood was seen. 
Histological examination showed normal architecture and liver cell 
appearance, although some proliferation of bile ducts was present (fig. 
III 7). In the liver hilus and along the intrahepatic branches of the portal 
vein, many extensively coiled arteries were noted. 
b Allogeneic transplantations 
Although recovery of the 13 animals, incorperated in the study, after the 
operation was very good, their clinical condition deteriorated progressively 
from the end of the fir~t week. Survival time varied from 6 to 22 days 
disregarding one animal which survived until killed .at the end of the 
observation period {fig. III 3 ). Mean and median survival time were 11.9 
and II days, respectively. 
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Fig. III 5. Productive capacity. 
Mean ± s.d. of Prothrombin, Thrombotest and Normotest activity and albumin levels of rats 
bearing liver transplants. The prothrombin activity was measured with the one stage method, 
using rat constituents (see text). 
Average body weight of the experimental animals (in% of preopera-
tive values) diminished sharply to 65%, 3 weeks after operation (fig. II! 
3). 
Hematocrit diminished from 48% (normal hematocrit) to 32% in 
two weeks (fig. Ill 3). In two animals hematocrit rose thereafter until 
they died. 
The incidence of jaundice became about three times as high as in 
the isografted series. Three days postoperatively already five of the 13 
animals (38.5%) were clearly jaundiced. At the I Oth postoperative day 
and at 14 days 90% and 85% of the animals were jaundiced respectively. 
In contrast, only 30% and none of the nine isografted animals were 
jaundiced at that time (fig. III 4 ). The elevated serum bilirubin was 
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conjugated in the majority of the animals suggesting that the hyper-
bilirubinaemia was mainly of the obstructive type. Maximal bilirubin 
values were 4.2 mg% at 4 days, 1.8 mg% at I week and 2.2 mg% at I 0 
days. 
Mean plasma albumin levels became very low (1.6 g/1 00 ml (fig. 
III 5). 
Impaired synthetic capacity of the alia-transplanted livers, was 
also reflected in the results of the clotting tests: mean prothrombin 
activity rapidly fell from normal levels to 40% I 0 days after transplan-
tation (fig. III 5). Although the five remaining animals had an increased 
clotting activity 4 days later, four animals died the subsequent week. 
Parallel to the results of the prothrombin activity measurements, Throm-
botest and Normotest values diminished to 45% of normal after I 0 days. 
At 14 days postoperatively an increase in clotting activity was noted in 
the 5 remaining animals (fig. III 5). 
One week after transplantation Bromsulphalein (BSP) excretion 
was low at I 0 and also at 30 minutes after injection of the dye (fig. 
III 4) 
SGPT did not rise to high levels. Significantly raised levels of 50 
mU/ml or more were present in 6 of the I I animals after 3 days. One 
week postoperatively, only 3 of the 9 remaining animals had raised 
SGPT-levels while 4 of the remaining 6 animals had high levels 3 days 
later (maximum 255 mU/ml) (fig. III 4). 
At necropsy all allografted livers were very much enlarged (twice 
to six times their original weight), and showed a dark red-brown colour; 
sometimes the liver Jobes were partly necrotic. Although not noticed 
clinically befo~e the animals were moribund, 9 of the 12 animals had 
yellow stained ascites, which also contained some blood. They all had 
distinct amounts of bile within their intestinal lumen indicating that 
the biliary anastomosis was functioning well. 
Histology of the liver grafts showed infiltration with mono-nuclear 
cells probably of lymphoid origin; this was especially prominant in the 
portal tracts. These cells extended into the liver parenchyma and were 
supposedly associated with haemorrhages from the liver sinusoids seen 
during the first week. Focal necrotic areas were increasingly seen during the 
second week(fig.IIl8). The animals which died in the third week after trans-
plantation had large areas of coagulative liver-infraction probably caused 
by intrahepatic thromboses of major portal branches (fig. HI 9). During 
the first two weeks after transplantation one animal's clinical condition 
deteriorated, while loss of liver function was noted. However, it 
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Fig. U16a, 6b. 
Spleno-portography of a rat after isologous liver transplantation. 
6a: the radioopaque dye is injected into the spleen: the portal vein and its intrahepatic branches 
are intensely stained. 
The heterotopic place of the liver is well recognisable, filling the right lateral side of the 
abdominal space. 
6b: the radioopaque dye is injected into a mesenteric vein and intensely stains the major 
intrahepatic portal vein branches. The photograph is taken in a later phase than 6a showing 
an even distribution of the dye through the liver sinusoids. 
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Fig. III 7. 
Rat liver isograft. Untreated animal, 7 weeks after transplantation showing well preserved 
hepatocytes. There is some bile duct proliferation around the portal vein. Although the hepatic 
artery was not anastomosed at the time of transplantation several arteries are distinguishable. 
H.A.S. X 150. 
Fig. III 8. 
Rat liver allograft. Untreated animal, day 12 after transplantation. There is a strong mononuclear 
cell innltration along the portal vein, extending into the liver parenchyma. Focal necrotic areas 
are present. H.A.S. x 150. 
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Fig. m 9. 
Rat liver allograft. Untreated animal, day 12 after transplantation. Two major branches of the 
portal vein are seen with a thrombus. There is a large area of necrotic liver tissue and also a part 
in which the liver structure is partially preserved. H.A.S. x 60. 
Fig. III 10. 
Rat liver allograft. Untreated animal, day 49 after transplantation. Hepatocytes and liver architec-
ture are normal, there is some bile duct proliferation, several arteries are seen along the portal 
vein. H.A.S x 380. 
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ameliorated to an excellent clinical condition, gammg weight until 
preoperative values were reached, while also its liver function restored to 
normal. 
At autopsy no macroscopial abnormalities were noted, in particular 
no infracts of the liver were seen; nor were there signs of porto-splenic 
hypertension. Histology, at 50 days postoperatively revealed at that time 
nonnalliver tissue without any signs of rejection (fig. Ill I 0). 
Statistical evaluation using the test of Welch (Welch 1947, de Bruin 
1970), on a I% significance level, revealed significant differences 
between the iso- and allografted series of the following parameters: 
survival, weight, clotting tests, albumin and BSP-excretion. 
4 Discussion 
a Transplantation procedure 
Initially, postoperative mortality (defined as death within 48 hours of 
successful operation) was high: 30 animals died in the first series of 57 
transplanted animals (52%). Though the animals recovered from the 
anaesthetic and were clinically well for I - 6 hours after the operation, 
their condition thereafter deteriorated until death occurred, usually 
within 15 hours. The clinical pattern of these dying animals in fact 
resembled that seen after experimental temporary occlusion of the portal 
vein (v.d. Meer et al. !971 ). This high postoperative mortality was 
initially attributed to the liver transplantation procedure as such. How-
ever, several other factors had to be considered as a possible contribution 
for this high mortality. Overdosage of ether was readily prevented by 
temporary discontinuation of the ether administration. 
During the operation a decrease of body temperature to ± 26 oc 
was noted in the first series of transplanted animals. This may have been 
due to evaporation (and thus temperature loss) of fluid from the intes-
tines which were until then lateralised outside the recipients abdomen 
during the transplantation procedure. 
Through this lateralisation of the recipients intestines, direct 
stimulation of splanchnic nerve endings may also have led to a neuro-
genic fall in blood pressure. Thirdly, Aldrete (1969) recognised that 
preventive measures had to be taken in order to prevent diminuation of 
blood glucose levels during the transplantation procedure: 0.2 g glucose/ 
kg/hour should be administered. Further, not only external blood loss 
should be considered when giving a blood-transfusion but an unknown 
amount of blood is removed with the extirpated liver and in addition 
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some blood probably remains sequestrated in the viscera, kidneys and 
hind limbs. 
Three simple measures were taken in the subsequent series to 
prevent the four mentioned factors which could have contributed to 
the initial high postoperative mortality. First, the intestines were 
lateralized within the abdominal cavity, secondly not only the estimated 
extravascular blood loss of 0.5 ml was compensated for, but an additional 
blood transfusion of I ml isologous blood was given. Thirdly 1.5 ml 
glucose 5% was administered together with the blood to prevent 
hypoglycaemia. 
As a result, the early mortality was reduced from 30 of the first 57 
(52%) animals operated upon, to I out of 20, of the subsequently oper-
ated animals. This significant improvement could not be attributed to an 
increased dexterity of the operator since improvement was prompt and 
(intra) operative death remained ± 20% throughout this and subsequent 
series. 
b Liver function and pathology 
The biochemical analysis of liver function indicated that hepatic syn-
thetic capacity as reflected by albumin levels, F II values and the results 
of the other clotting tests, was significantly reduced during the acute 
rejection process of liver allografts. Since Thrombo- and Normotests gave 
practically the same mean coagulative activity percentages, one may 
conclude that no sign of vitamin K deficiency was present at any time 
of the study (Hemker and Muller 1968, Owren 1969). As expected, the 
BSP excretion was decreased, also indicating hepatocellular damage. 
In the isografted rats, BSP excretion during the first I 0 minutes 
after its injection, was increased above normal. This indicates that the 
number of liver cells available for detoxication was increased (Cornelius 
et a!. 1967, de Leeuw-lsrael, 1971 ). Interestingly the mean liver mass of 
the isografted rats was 11.4 g after seven weeks, while the male recipients 
original liver weight at the time of transplantation was only 8. 7 g and the 
female donor liver at the time of transplantation weighed only 6.8 g. 
Thus the increase in liver weight does not seem to be limited by intrinsic 
factors, that is genetically determined within the (female donor) liver 
cells, but considerable influence must have come from outside the liver. 
Since the productive capacity of the liver had become normal, as may be 
concluded from the normal clotting activities, or close to normal (see 
albumin levels), it suggests that the liver has a lower productive capacity 
per unit of cell. This may have been the consequence of lower oxygena-
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tion (only portal blood was provided for the liver) or other hemodynamic 
factors. The data favour the concept that there exists a controlling 
mechanism based on the maintenance of a constant functioning hepatic 
cell mass: body weight ratio (Maki and S!apak, 1974). The fact that 
there was overcompensation of excretory function and of mass rather 
than of productive capacity suggests that the latter provides the stimulus 
for compensatory liver growth. 
Survival time of the untreated non-auxiliary liver allografted animals 
was similar to that seen in untreated kidney allografted animals of 
the same strains (de Bruin 1970, Tinbergen 1972), the kidneys being 
transplanted across the same strong histocompatibility barrier (H-1 
histocompatibility locus (Stark and Kren 1969, Stark eta!. 1969). This 
is not the case when livers are transplanted using the auxiliary method of 
transplantation. Although the major Ag-B locus is not a strong locus in 
the Buffalo rat strain (Guttman et al. 1967, Murray 1969), total or 30% 
auxiliary liver allografts between Buffalo and Lewis rats appeared to be 
completely infarcted by day 14 (Fisher and Fisher 1970). In Lee and 
Edginton's studies all auxiliary liver grafts were destroyed by day I 0 or 
II. Our own experiments in which auxiliary grafts were used (chapter 
II) also indicated a shorter survival time of the allografted liver when 
compared to non-auxiliary liver grafts. 
The present experiments indicate that liver cell proliferation is 
strongly stimulated in non-auxiliary liver allografts, leading to a some-
what prolonged survival and apparently an increase of functioning liver 
mass. In this respect it is interesting to note that one animal survived 
the acute rejection period, although functional analysis revealed severe 
impairment of liver function during that time. Even more interesting is 
the fact that histopathological examination of the grafter liver 7 weeks 
after transplantation showed no signs of rejection or cell damage 
whatsoever. Apparently the recipient had accepted the transplanted organ. 
We have not carried out liver biopsies in order to obtain histopatholocial 
proof of rejection in this animal. Hence, we can only point to the similar 
function pattern of this and other animals while we have no absolute 
proof that indeed rejection did occur at I 0 days after transplantation. 
The same phenomenon was noted in respect to kidney transplantation 
in the rat by Dunn and Rendall (1974) and they suggested that auto-
enhancement might be the reason for this prolongation of survival. It 
is not known if similar processes like tolerance or enhancement as 
supposed by Caine (1969) in respect to pig liver transplantation played a 
role. 
51 
Other workers (de Bruin 1970, Lubbe eta!. 1972, Vuzevski, 1976) 
have described that in the rejection of organ transplants two different 
types of lesions are noticed: 
I. a lesion of capillary endothelium and parenchymal cells associated 
with lymphoid cell infiltration, probably to be explained by a cell-
mediated rejection, and 
2. an inflammation and necrosis of the larger transplant arteries 
and veins associated with deposition of IgG and complement in the 
vascular wall. This so-called vascular rejection is possibly the result 
of an antibody-mediated reaction. 
Histopathological examination revealed that unmodified rat liver rejec-
tion also had two main features: animals dying within I \1, weeks predom-
inantly showed acute rejection which had the features of a cell medicated 
process. During the first week the portal tracts were increasingly invaded 
by mononuclear cells which also infiltrated between the liver cells 
apparently causing liver sinusoid rupture with haemorrhages and individ-
ual liver cell loss (fig. III 8). Animals dying after two weeks showed 
endothelial proliferation, necroses of the wall of the portal veins and 
portal vein thromboses, possibly associated with an antibody mediated 
process (fig. III 9). The acute rejection pattern of these liver allografted 
rats is in contrast to procine liver transplantation (Caine et a!. 1967a) 
and is comparable to that seen in canine, monkey and human liver 
transplantation (My burgh et al. 1971, Porter 1969). 
In clinical and experimental liver transplantation, the biliary-
intestinal anastomosis and the portal vein are the suspected sites for 
ascending infections (Starzl 1969, Starzl et al. !975, Murray-Lyon et al. 
1970, Schalm et al. 1972, Schalm et al. 1975, Williams et al. 1973). 
The susceptibility to this infection seems to be promoted by the rejec-
tion process. Histologically we have seen however, no cases of dissimina-
ted focuses of bacterial growth. This may be explained by the fact that 
we used specific pathogen-free animals and treated them during three 
weeks with antibiotics. 
In our series, many animals developed yellow-brown stained ascites 
during the final stage of rejection. Macroscopic examination and 
histology showed that at that stage the extrahepatic biliary tract was 
intact and unobstructed by the rejection process. Since many 
hepatocytes were still working at that time, the ascites must have been of 
transhepatic origin. 
In the liver isografts a great number of arteries was observed than 
in the untransplanted liver. This was not found up to 3 weeks after 
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transplantation in a separate series of animals which were sequentially 
killed. Possibly, re-arterialisation occurred, the new arteries being formed 
along the portal tracts. 
In 1972 we preliminary reported on the results of the non-auxiliary 
transplantation model as described above (Wolff 1972). It is relatively 
simple, can be performed by one person in one hour, and because of the 
sequence of operative actions, it circumvents the need for a blood shunt 
from the portal vein to the jugular vein, while the recipient is not 
anhepatic at any time of the operation. Rats bearing isogeneic liver 
transplants, placed heterotopically as described above were able to sur-
vive up to 1 Y, years without indications of diminuation of liver function. 
Recently another non-auxiliary way of transplantation was described 
(Lee et a!. 1974) using the classical orthotopic liver transplantation 
technique in the rat. Although in that way the liver transplant is clearly 
in a more physiological position, the procedure is more difficult to 
perform and it necessitates a porto-jugular shunt. 
Donor livers in our series, half the size of the original recipient 
livers, were able to function adequately and to maintain the 100% 
hepatectomized recipient in a healthy state. The strong proliferative 
activity of the livers as shown in our experiments may have clinical 
implications. It suggests that, livers from infants might be used for 
orthotopic transplantation in one to three year old children or children's 
livers for adult recipients (Caine 1969, Ranson eta!. 1972). 
The technique of non-auxiliary liver transplantation in rats as 
described above, may be useful in studying the patho-physiologic 
consequences of various immunosuppressive regimens. 
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Chapter IV 
IMMUNOSUPPRESSIVE THERAPY OF LIVER 
ALLOGRAFTED RATS 
I . Introduction 
Experimental allo-transplantation of such organs as heart. kidney, skin, 
intestines, islets of Langerhans or bone marrow between inbred rat 
strains, have provided valuable information on rejection and function of 
the allograft. Different immunosuppressive regimens have been tested in 
rodents with such transplants (v. Bekkum eta!. 1969, de Bruin 1970, 
Kart et al. 1973, Marque! and v. Bekkum 1973, Marquet and Heystek 
1975, Tutscka and Santos 1975, Wustrack et al. 1975). However, in the 
case of liver transplantation so far only larger animals could be used 
(Chandler et al. 1972, My burgh and Smit 1975, Starzl et al. 1965). 
Immunosuppression of liver allografted rats could not be adequately 
investigated because a life-sustaining part of host liver had to be left 
within the recipient rat. Often the auxiliary liver allografts in rats were 
rejected within 14 days without significant loss of liver function or clear 
signs of liver cell damage, while the animals remained alive and in good 
condition (personal observation). 
A liver transplantation technique in which no functional host liver 
tissue was left at the time of transplantation provided the possibility to 
study survival of the animals, as well as the function of the grafted liver 
(chapter III). "Functional competition" between the graft and the host 
liver would not influence the fate of the graft, and changes in liver function 
would in fact reflect the different aspects of rejection. In the experi-
ments described here, a number of immunosuppressive regimens were 
used in rats, carrying such life-sustaining allotransplanted livers. 
2. Material and methods 
a. Animals. 
Inbred specific pathogen free rats of the same strains as described in 
chapter Ill were used. Female BN/Bi rats were used as liver donors. 
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Male animals of the Wag/Rij strain served as recipients to be treated with 
immunosuppressants. The liver isografted group of BN/Bi rats described 
in chapter III served as control animals. 
b. Surgical technique. Antibiotic treatment. 
The surgical technique as well as antibiotic treatment were as described 
in chapter Ill. Whole female livers (weighing 6.08 ± 0.50 g) were hetero-
topically transplanted into hepatectomized recipients (male BN livers 
weighed 8.70 ± g and Wag livers weighed 9.58 ± 0.62 g). Antibiotic 
treatment consisted of daily doses of 10,000 I.U. penicillin, I 0 mg 
streptomycin and 20 mg cephaloridin s.c. given during 3 weeks follow-
ing the operation. 
c. Laboratory techniques. 
The techniques and frequency of determinations were as described in 
chapter III. 
Body weight measurements and haematocrit determinations were 
performed bi-weekly. Synthetic capacity of the liver was evaluated by 
albumin measurements and clotting activity tests. Prothrombin (FII) 
was measured with a one stage method (Owren 1949) using rat 
thromboplastin and prothombin deficient rat plasma (chapter III). 
Excretory capacity of the livers: total and conjugated bilirubin measure-
ments and sequential bromsulphtalein (B.S.P.)retion tests were performed. 
SGPT, indicating possible liver cell loss, was regularly measured in all 
animals. Portal vein radiography was performed at 7 weeks. The animals 
were then killed during the same anaesthesia and the relevant organs for 
histological examination removed. Paraffin-embedded sections of 5!1 
thickness were routinely stained with hematoxilin, azophloxin and 
saffron (H.A.S.). 
d. Immunosuppression and experimental design. 
One badge of horse Anti Rat Lymphocyte Globulin (ALG) (kindly 
provided by the Radiobiological Institute TNO, Rijswijk) was used in 
two of the experimental groups. It was produced and purified in the 
same way as described for horse anti monkey lymphocyte globulin 
(Bainer et a!. 1970). When tested in vivo, in the same weekly dose 
regimen as used in these liver allograft studies, it effectively prolonged 
skin allograft survival between inbred rat strains. Azathioprine (Imu-
ran®, Burroughs Wellcome, London) and Prednisolone sodium succinate 
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(Organon, Oss, Holland) were administered for three weeks after the 
transplantation. A period of three weeks to treat the animals was chosen 
since it was known that unmodified rejection of the allografted liver 
occurred within this period in the majority of the animals (chapter III). 
It was also known that the majority ofliver homograft rejections, in spite of 
immunosuppressive treatment, in dogs or monkeys, occur within 50 days 
(Myburgh eta!. 1971, Starzl eta!. 1965). Thus,anobservation period of 
seven weeks was chosen since this seemed a reasonable period to study 
the acute rejection of the transplanted livers. It also allowed comparison 
with experiments concerning rat kidney grafts and immunosuppression 
(de Bruin 1970). 
The experimental groups were: 
I One group of nine allografted recipients was treated with ALG 
only. The ALG treatment consisted of 4 intra-peritoneal injections 
of I ml: day -7, day 0 (day of operation), day +7 and day +14. 
II A second group of I 0 animals received daily 4 mg/kg .azathioprine 
s.c. from day 0 to day 21. 
III A third group of I 0 animals received a combination of the treat-
ment of group I and II, i.e. ALG and 4 mg/kg azathioprine. 
IV A fourth group of 9 animals was treated with daily s.c. injections of 
prednisolone 4 mg/kg and azathioprine 2 mg/kg during three weeks 
after transplantation. 
3. Results 
Fiftythree allotransplantations were performed. Fourteen animals died 
during the operation or within 48 hours after transplantation. Since their 
death could be related to technical errors, they were excluded from the 
experiment. 
a Liver function 
Group I 
The nine ALG treated animals survived in excellant clinical condition, 
comparable to non transplanted or isografted animals, until they were 
killed. However, two of these animals were accidentally killed, by an 
overdosage of ether, 4 and 5 weeks respectively after transplantation 
(fig. IV I). The results of the liver function tests were also good (the two 
animals, which were accidentally killed, were included in the results). 
Mean weight (fig. IV 2) was only slightly lower than that of the 
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isografted group. Haematocrit and albumin values (fig. IV 3, IV 4) were 
higher than those of the isografted group. Prothrombin (fig. IV 5) did 
not differ, but BSP excretion (fig. IV 6) became better than the results 
of the isografted group. The proportion of animals with an elevated 
serum bilirubin (> 0.5 mg/ml) was somewhat greater than in the group 
of isografted animals (fig. IV 7). 
Group II 
Of this group, treated with azathioprine 4 mg/kg, 5 of the l 0 animals 
died during the first two weeks after transplantation (fig. IV l ). During 
this time, the results of the weight, haematocrit, albumin, prothrombin 
and BSP excretion estimations were depressed in all ten animals (fig. 
IV 2 - 6). In the animals that died spontaneously, at autopsy a pale 
donor liver with haemorrhages was found. Haemorrhages were also found 
scattered over the body, for instance subcutaneously, in the lungs, 
intestinal wall and occasionally in the testes. In those animals which 
survived the first two weeks, the results of the function tests tended to 
normalise, which was closely correlated with an amelioration of the 
clinical condition of these animals. 
Group III 
Azathioprine 4 mg/kg added to the ALG treatment gave low values of 
weight, haematocrit and albumin determinations, especially so when 
compared to the group treated with ALG alone (fig. IV 2-4 ). All l 0 
animals survived for 3 weeks after the liver transplantation but 3 animals 
subsequently died within 3 days, an additional death occurring 2 weeks 
later, leaving 6 out of 10 animals to survive the observation period of 7 
weeks (fig. IV I). The animals which died at 3 and 5 weeks post oper-
atively were found to have at autopsy dispersed haemorrhages and very 
pale bone marrow. Blood congestion as well as haemorrhagic areas were 
found in the donor livers. Macroscopically, also thrombotic processes 
within the caval vein, adherent to the ligated suprahepatic part of the 
donors caval vein and partly occluding the efferent traject of blood flow 
through the liver, were found. 
Group IV 
Although initially all nine animals treated with azathioprine 2 mg/kg and 
prednisolone 4 mg/kg clinically recovered quite well after the 
transplantation, their clinical condition deteriorated after approximately 
3 days. Four deaths occurred within the first post operative week (fig. 
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Number of animals with bilirubin ~ 5 mg/ml after receiving a liver isograft without immuno~ 
suppression, or liver allograft, with a different immunosuppressive regimen. 
IV I). Liver function, as reflected by the mean albumin values and 
prothrombin activities were however not significantly impaired (fig. 
IV 4, 5 table IV I). Autopsy on the animals that died spontaneously 
showed that thrombotic processes partly occluding the intrahepatic 
caval vein but also wound dehiscention and peritonitis were present. 
In three animals significant intra-abdominal or external blood loss had 
obviously occurred. 
Mean SGPT values of the allografted animals were elevated (> 
50 mU/ml) immediately after the operation and even more so 1¥2 to 2 
weeks after the operation. The values normalised in the following 5 
weeks. There were no significant differences noted between the differ-
ently treated groups. 
B.S.P. excretion rates, during the first I 0 minutes after injection of 
the dye, were significantly better in the ALG treated group than in the 
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Fig. IV 8. 
Spleno-portography of a rat, after allotransplantation of the liver and treatment with ALG. 
A There is good visualisation of the portal vein and its intrahepatic branches. 
B Picture taken in a later phase than A, there is an even distribution of the radio-opaque dye 
through the portal vein and its branches but it is also evenly distributed through the liver 
sinusoids. 
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Fig. IV 9. 
Rat liver allograft, 7 weeks after transplantation. Animal treated with ALG. The liver paren-
chyma is well preserved. There is little mononuclear infiltration. H.A.S. x 150. 
Fig. IV 10. 
Rat liver allograft, 7 weeks after transplantation. Animal treated with ALG and Imuran 4 mg/kg/ 
day. Preservation of liver parenchyma is good. There is little mononuclear cell infiltration into 
the portal triangles. H.A.S. x 150. 
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Fig. N II. 
Rat liver allograft, 7 weeks after transplantation. Animal treated with Imuran 4 mg/kg/day. In 
general the liver parenchyma is well preserved, but there is evidence of cholanchitis and liver cell 
loss. H.A.S. x 150. 
Fig. N 12. 
Rat liver allograft, 7 weeks after transplantation. Animal treated with Imuran 2 mg/kg/day and 
Prednisolone 4 mg/kg/day. The liver tissue is well preserved and there is only moderate 
mononuclear cell inltltration H.A.S. x 150. 
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isografted group (fig. N 6, table IV 1). Those animals treated with aza-
thioprine alone, or in combination with ALG or Prednisolone however, 
had initially a lower excretion rate than the isografted animals, later, 
they had good but variable excretion of the dye. 
Statistical evaluation of the results using the test of Welch (1947) is 
summarised in table IV I. 
Spleno-portografy at 50 days showed that the portal veins of all 
animals were functioning well, their branches being distributed evenly 
into the periphery of the liver transplants. Also the hepatogram showed 
a regular sinusoidal distribution of the roentgen opaque dye 
(fig. IV 8 A, B). 
b Histology (fig. IV 9-12) 
Histology of the livers of all animals surviving for 50 days, showed that 
the general architecture of the livers was well preserved and that the liver 
cells appeared normal. Along the portal veins, many vessels with a 
muscular media and normal intima (arteries), were noted. 
Group I 
In the ALG treated animals histology showed that well preserved and 
regenerating liver tissue was present. There were moderate signs of bile 
duct proliferation, sometimes with evidence of cholanchitis, that is 
mononuclear and polynuclear cell infiltration around the bile ducts 
and the biliary structures in the liver hilus. There was hardly any mono-
nuclear cell infiltration within the liver, associated with liver cell damage 
(fig. IV 9). 
Group II 
The animals of the group treated with azathioprine 4 mg/kg/day, which 
died spontaneously, had histologic signs of liver cell damage: fatty 
degeneration of the liver cells. Major ischaemic liver infarcts or infarcts 
congested with blood, due to thrombotic occlusion of the portal vein or 
caval vein of the donor liver, were also seen. In other animals bone 
marrow aplasia was diagnosed: myeloid and erythroid precurser cells 
together with a solitary megacaryocyte were only scarcely seen. There 
were histologic evidences of a herewith associated multifocal bacterial 
invasion of the animals. Histology at 50 days showed a more pronounced 
cholanchitis than in the ALG treated animals. Substantial mononuclear 
infiltration with lymphocytes and plasma cells, associated with multi-
focal, hepato-cellular necroses was noted (fig. IV II). 
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fable IV 1. Statistical evaluation of the differences between liver isografted control animals and 
the differently treated allografted rats, tested on a 1% level of significance. + = 
significantly higher, - = significantly lower, 0 = no significant difference. 
isografted allografted animals 
animals 
untreated ALG Azathio- ALG+ Azathio-
prine Azathio- prine 
4 mg/kg prine 2 mg/kg 
4 mg/kg +Pred. 
4 mg/kg 
Isografted weight X + + + + 
animals Hct X + + 0 
untreated Albumin X 0 0 0 0 
Protrombin X 0 + 0 0 
BSP X 0 0 0 
Allografted weight X + + + 
animals Hct + X + + + 
ALG Albumin 0 X 0 + 0 
Protrombin 0 X + 0 0 
BSP + X 0 0 0 
Allografted weight X 0 + 
animals Hct X 0 
Azathio- Albumin 0 0 X 0 
prine Protrombin X 
BSP 0 0 X 0 0 
Al!ografted weight 0 X + 
animals Hct 0 X 
ALG+ Albumin 0 0 X 
Azathio- Protrombin 0 0 + X 0 
prine BSP 0 0 0 X 0 
A!lografted weight X 
animals Hct 0 + + X 
Azathio- Albumin 0 0 + + X 
prine + Protrombin 0 0 + 0 X 
Predniso- BSP 0 0 0 0 X 
lone 
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Group III 
Microscopic evidence of the complications, leading to spontaneous death 
as noted in group II (azathioprine 4 mg/kg/day) was also seen in the 
group treated with ALG in combination with azathioprine 4 mg/kg/day. 
After 50 days virtually the same picture was seen as in recipients treated 
with ALG alone (fig. IV I 0). 
Group IV 
7 Animals died spontaneously after treatment with prednisolone 
4 mg/kg/day together with azathioprine 2 mg/kg/day. Mononuclear 
infiltration was increasingly seen with time not only in the portal triangles, 
but also in between the liver parenchyma. In the animals dying ± I 
week after transplantation, vacuolar degeneration, atrophy and liver cell 
death was noted. The two animals of this group which survived the 50 
days after liver transplantation, had only moderate mononuclear inf:tltra-
tion in the donor livers (fig. IV 12). 
4. Discussion 
The advantages of using inbred rat strams were confirmed in this study 
of rats with life sustaining liver transplants. Intra-operative mortality and 
post-operative mortality (death within 48 hours after operation) together 
are ± 26%, showing that the transplantation technique is feasable and is 
highly reproducable. The technique is well-suited to investigate the effects 
of immunosuppressive therapy and histocompatibility differences. In 
respect to the immunosuppressive agents used, several observations can 
be made. 
First, the complications caused by the use of azathioprine (lmuran) 
are considerable. It is known, that Imuran is hepatotoxic (Starzll969) and 
that it is metabolised in the intact liver while only thederivativesarerespon-
sible for its immunosuppressive activity (Bach, 1972). It is therefore not 
surprising that we observed signs of toxicity: strong diminution of liver 
function and histologic signs of liver cell damage. In other animals bone 
marrow aplasia, with consequent anaemia, haemorrhagic diathesis and 
susceptibility to fulminant infections was observed. In our series a 50% 
mortality was obtained within 2 weeks after transplantation in the aza-
thioprine treated group, this is similar to results of rat kidney transplan-
tation in the same inbred rat strains, in which, with identical immuno-
suppressive therapy 40% survival was obtained (Tinbergen 1968, de 
Bruin, 1970). 
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The side effects of Imuran i.e. bone marrow aplasia and hepato-
toxicity are similar to those observed by Starzl (1969) in human liver 
transplantation. Further (experimental) evaluation of less hepatotoxic 
immunosuppressants (for instance cyclofosfamide) seems to be indicated. 
Secondly, in the group in which Imuran 2 mg/kg was combined 
with prednisolone 4 mg/kg, only 22% survival after 50 days occurred. 
This is in contrast with kidney transplantation in which with the same 
rat strains and host-donor combination survival was 80% (de Bruin 1970). 
The liver function tests clearly point to a progressive loss of liver 
function in the Imuran treated animals, while the liver function of the 
Imuran/prednisolone treated group did not diminish. Autopsy on the 
prednisolone treated animals that died showed that infections and 
wound dehiscention were the major problems in these animals. 
Thus, it is likely, that the doses of prednisolone should be kept 
as low as possible shortly after liver transplantation. One may then 
prevent impairment of connective tissue repair and also prevent a possible 
decrease of liver cell proliferation. Both side effects of prednisolone 
were noted, using the same immunosuppressive dosages, in a rat model 
of liver regeneration (Kort and v.d. Post !973). Imuran 4 mg/kg added 
to ALG gave some deaths presumably caused by bone marrow depression. 
The efficacy of the immunosuppressants used, could be evaluated 
through the results of repeated micro biochemical determinations invol-
ving liver synthesis, detoxication and excretion. It became evident that 
some immunosuppressive regimens, while giving adequate results in rat 
kidney transplantation, cannot be transferred without modifications 
to experimental rat liver transplantation. This probably holds true for 
man too. 
The advantages of the use of a highly effective, non-toxic ALG 
(horse anti lymphocyte gammaglobulin) was confirmed in this rat liver 
transplantation model. It was clearly superior to all other immuno-
suppressants used. It was not hepatotoxic as described by others (Koumans 
et a!. 1972) nor did it induce anaemia. All animals survived, hepatic 
function and histology were within normal limits and portal vein radio-
graphy showed no abnormalities. The fact that ALG, given alone during 
three weeks, was superior to the other immunosuppressive regimens 
tested, may however not be translated to the human situation without 
further research. In 1971, My burgh and co-workers used a horse anti 
monkey lymphocyte globulin which had been tested in vitro. Using this 
ALG in baboons only I 0 to 20 percent survivors were obtained 50 days 
after orthotopic liver transplantation. Apparently, a high lymphocytotoxic 
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titer of 1 : 8,000 and rosette inhibition titer of 1 : 8,000 and a seemingly 
adequate dosage scheme did not guarantee its effectiveness. A re-evalua-
tion of ALG with known in vivo immunosuppressive activity in sub-
human primates is of special importance, since this animal species is 
generally considered as the best for these sort of experiments. Indeed, it 
is well known that different batches of ALG may have quite different 
immunosuppressive activity and/or toxicity (Bainer et a1.1970, 
Koumans et al. 1972, Brendel 1973, 1975). The activity and toxicity of 
ALG for experimental use can be tested in vivo in well known animal 
transplantation models before it is used in a specific experiment. For 
instance skin allotransplants can be used in the rat or monkey for the 
purpose of testing anti-rat or anti-monkey lymphocyte sera (Bainer 
et al. 1970). But, ALG cannot be tested in this way (in vivo) in humans. 
In heart transplantation therefore, an in vitro test system is used, based 
on tbe spontaneous rosette inhibition test of Bach et al. (1969). The 
results, this time, were promising. The dosages given in fact, could be 
adjusted to the circulating levels of ALG. It seemed further, that the 
levels of ALG, corrected for their rosette inhibition titers indeed 
positively correlated with the time interval between the operation and 
the onset of the first rejection of the transplanted heart (Schroeder et 
al. 1976). The provision of a highly effective, non-toxic anti-human 
lymphocyte globulin is however not the only problem encountered. The 
heterologous serum proteins namely invoke, apart from hypersensitivity 
reactions, antigen-antibody complexes which may get trapped, together 
with complement, in the renal glomerular filter and cause a pronounced 
glomerulopathy (Cohen et al. 1970). Recently these problems were also 
described in the human recipients of liver transplants (Cubilla et al. 
1974 ). In conclusion, although ALG was highly effective in preventing 
liver allograft rejection and no adverse effects were noted in these rats, 
further experiments are required. Not only rats, but also the canine species 
and subhuman primates should be incorporated in these studies of liver 
transplantation and immunosuppression. 
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SUMMARY 
The main indications for liver transplantation are acute or sub-acute liver 
necrosis, viral hepatitis and cirrhosis. From the literature one learns that 
also children with biliary atreasia are considered potential recipients of a 
liver transplant. However, according to Kasai (1974), patients with 
biliary atreasia have a prognosis of 80% cure when a modified hepato-
portoenterostomy operation is performed before the patient is ten weeks 
old. This statement does however need confirmation. 
Since only 15 patients with this type of diagnosis are to be 
expected in the Netherlands per year, centralisation of the efforts is a 
prerequisite. Only then, the necessary experience in treatment and 
operation of these children can be obtained. From the number of 
patients dying of the heretofore mentioned liver diseases, it is estimated 
that about 25 children under 15 years and 58 patients up to 50 years 
could be considered for liver transplantation per year, when, at least, the 
patients with biliary atreasia are incorporated in this group. 
The results of liver transplantation compare unfavourably with 
those of heart transplantation (Bergan 1975). The reason why only 3.3% 
of the patients survive 3 years after the operation, is primarily caused by 
the high frequency of bacterial infections. In a series of 83 patients, 42% 
died of infectious complications. The intimate contact of the liver, via 
the biliary tract and the portal vein, with the intestines renders it 
particularly susceptible to bacterial and or viral invasion. 
Immunosuppressive treatment after liver transplantation is largely 
based upon experience from clinical and experimental kidney transplan-
tation. Investigations in dogs and monkeys proved that pronounced 
individual differences were obtained after liver transplantation when the 
animals received immunosuppressive treatment. Probably the unpredic-
table influence of individual differences in histocompatibility and 
immune responsiveness play a significant role in these results. 
The purpose of the investigations in this thesis was to provide a liver 
transplantation model in which genetic influences would be controlled. 
Thus the inbred rat was chosen as the experimental animal. When the 
technique was developed, different immunosuppressive regimens were 
compared for their effectiveness in suppressing liver transplant rejection. 
In chapter II a modified technique for auxiliary liver transplan-
tation is described. Post-operative 4 day survival, improved from 27% 
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with the existing method, to 87% with the modified technique, which 
used the infra hepatic vena cava as the efferent vessel from the liver graft. 
Chapter III describes a life sustaining (non auxiliary) liver trans-
plantation technique. Operative mortality was about 20%. Several 
biochemical determinations were adjusted or developed on a micro-scale 
in order to assess the condition of the transplanted liver. These 
determinations were made first bi-weekly, later, once a week. 
No immunosuppressive treatment was given to rats with isogeneic 
or allogeneic liver transplants. The rats with isogeneic grafts remained 
in good condition, and had concommittant good liver function. The 
following parameters were used: general (survival, weight, haemato-
crit), liver production (albumin, and clotting activity tested through 
Prothrombin, Thrombotest® and Normotest®), excretion (B.S.P. 
excretory capacity and bilirubin) and liver cell loss (SGPT). They all 
normalised during the seven week observation period. Portal vein radio-
graphy revealed that, after seven week observation period, blood flow 
through the grafted livers was normal. 
Mean survival time of the allografted animals was II .9 days. The 
results of the biochemical estimations correlated with the severity of 
the histopathological changes (indicative of graft rejection), noted after 
their death. 
In chapter IV the effects of different immunosuppressive regimens 
given during three weeks after transplantation are compared. The liver 
function and histopathology of the allotransplanted rats are described. 
Through ALG (I ml/week) rejection was effectively suppressed while 
the function of the livers was normal. When azathioprine (4 mg/kg/day) 
was added to the prior treatment, 4 out of I 0 animals died of the 
consequences of bone marrow aplasia, a well known side effect of 
azathioprine. When azathioprine was given alone (4 mg/kg/day) the liver 
function progressively diminished and 50% of the animals died within 2 
weeks. The surviving animals recuperated well from their rejection and 
liver function was restored during the following period. The post-
operative mortality was high in the group treated with prednisolone 
(4 mg/kg/day) and azathioprine (2 mg/kg/day). General impairment of 
the animals' condition and retarded wound healing rather than impair-
ment of liver function was the cause of death in these cases. 
From these data it is concluded that treatment with ALG was 
clearly superior to the other immunosuppressive treatments, such as 
azathioprine, with or without ALG or prednisolone. 
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SAMENVATTING 
De belangrijkste indicaties voor lever transplantatie zijn acute of sub-
acute levernecrose, virus hepatitis en cirrose. Uit de Jiteratuur blijkt dat 
kinderen met galgang-atresie ook als potentiele ontvangers van een lever-
transplantaat worden beschouwd. Kasai (1974) is echter van mening dat 
patienten met galgang-atresie een kans van 80% op genezing hebben mits, 
binnen I 0 we ken na de geboorte, een gemodificeerde hepatoporto-
enterostomie operatie wordt uitgevoerd. Deze uitspraak dient nog te 
worden bevestigd. 
Op grond van het aantal patienten die jaarlijks overlijden ten ge-
volge van de hierboven genoemde ziekten kan men een schatting maken 
van het aantal mogelijke candidaten voor levertransplantatie in Neder-
land. Deze groep zal bestaan uit ongeveer 25 kinderen tot IS jaar en 58 
patienten van IS tot 50 jaar, indien patienten met galgang-atresie worden 
meegerekend. 
De resultaten van Jevertransplantatie zijn slecht in vergelijking met 
die van harttransplantatie (Bergan 1975). Het feit dat slechts 3,3% van de 
patienten de opera tie 3 jaar overleeft is voor een groot dee! te wijten aan 
het hoge aantal bacteriele infecties. In een serie van 83 patienten stierf 
42% ten gevolge van infectieuze complicaties. Het nauwe contact dat de 
lever via de galwegen en de vena porta met de darrnen heeft verklaart de 
bijzondere gevoeligheid voor infecties. 
De immunosuppressieve behandeling na Jevertransplantatie berust 
voornamelijk op ervaringen afkomstig van klinische en experimentele 
niertransplantatie. Onderzoek bij honden en apen heeft aangetoond dat 
er aanzienlijke individuele verschillen in overleving zijn wanneer de 
dieren na de Jevertransplantatie een immunosuppressieve behandeling 
krijgen. Waarschijnlijk zijn de onvoorspelbare invloeden van histocom-
patibiliteit en immuunreactiviteit daarbij van grote betekenis. 
Het doe! van het in dit proefschrift beschreven onderzoek was, een 
techniek voor levertransplantatie te verkrijgen waarin de genetische 
invloeden constant konden worden gehouden. Om deze reden werden 
ingeteelde rattestammen gebruikt. Toen deze techniek was ontwikkeld, 
kon worden overgegaan tot het vergelijken van verschillende immuno-
suppressieve regimes om hun waarde te bepalen voor het onderdrukken 
van de afstotingsreactie. 
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In hoofdstuk II wordt een gemodificeerde techniek voor auxiliaire 
transplantatie beschreven. Het overlevingspercentage, 4 dagen na de 
operatie, nam toe van 27% met de bestaande methode tot 87% met de 
gemodificeerde methode. Daarbij werd gebruik gemaakt van de vena cava 
infra-hepatica als afvoerend bloedvat van de lever. 
Hoofdstuk III beschrijft een levertransplantatietechniek waarbij de 
ontvanger geheel afhankelijk is van de functie van de getransplanteerde 
lever (niet auxiliaire levertransplantatie). De mortaliteit rond de operatie 
was ongeveer 20%. Verschillende biochemische bepalingen werden aange-
past of ontwikkeld om op microschaal de functie van de getransplanteer-
de lever te kunnen bepalen. Deze bepalingen werden eerst twee maal en 
later een maal per week uitgevoerd. 
Aan twee groepen ratten met isogene of allogene levertransplan-
taten werd een immunosuppressieve behandeling onthouden. De ratten 
met isogene transplantaten bleven in goede conditie en hadden een 
daarmee overeenstemmende goede lever functie. De volgende parameters 
werden gebruikt: algemene (overleving, gewicht, heamatocriet), eiwit 
productie (albumine en stollingsactiviteit, gemeten via prothrombine, 
Thrombotest® en Normotest® bepalingen), uitscheiding (B.S.P. uit-
scheidingscapaciteit en bilirubine) en levercel verval (SGPT). Zij werden 
allen normaal gedurende de zeven weken durende observatieperiode. 
Met spleno-portografie werd aangetoond dat, zeven weken na de opera tie, 
de bloed doorstroming door de levertransplantaten normaal was. 
De gemiddelde overlevingsduur van de allogeen getransplanteerde 
dieren was ll ,9 dagen. De uitslagen van de biochemische bepalingen 
weerspiegelden de ernst van de afstotingsreactie welke bij het post-
mortem onderzoek histologisch gevonden werd. 
In hoofdstuk IV worden de resultaten vergeleken van verschillende 
immunosuppressieve behandelingen, die gedurende drie weken na de 
transplantatie werden toegepast. De leverfunctie en de histopathologie 
van de allogeen getransplanteerde ratten worden beschreven. 
Door Anti Lymphocyten Globuline (ALG) (l mg/week) werd de 
afstoting doeltreffend onderdrukt terwijl de levers normaal functio-
neerden. Vier van de l 0 dieren stierven als gevolg van beenmerg-aplasie 
na behandeling met ALG en azathioprine (4 mg/kg/dag). Beenmerg-
aplasie is een bekende bijwerking van azathioprine. Wanneer azathioprine 
aileen werd gegeven ( 4 mg/kg/ dag) dan werd de leverfunctie geleidelijk aan 
minder en stierf 50% van de dieren binnen twee weken. Bij de dieren 
welke de afstotingsreactie overleefden, werd de leverfunctie geleidelijk 
aan normaal. De postoperatieve mortaliteit was hoog wanneer de dieren 
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met prednisolon (4 mg/kg/dag) en azathioprine (2 mg/kg/dag) werden 
behandeld. De doodsoorzaak was in deze gevallen eerder een verminde-
ring van de algemene conditie van de dieren en vertraagde wondgenezing 
dan een vermindering van de leverfunctie. 
Uit deze gegevens wordt geconcludeerd dat de behandeling met 
ALG duidelijk superieur was aan de andere immunosuppressieve behan-
delingen zoals toediening van azathioprine, aldan niet in combinatie met 
ALG of prednisolon. 
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